Updated on 2024/03/21

写真a

 
HONDA, Takashi
 
Organization
Nagoya University Hospital Gastroenterology Lecturer
Graduate School
Graduate School of Medicine
Title
Lecturer

Degree 1

  1. 医学博士 ( 2004.3   名古屋大学 ) 

Research Interests 7

  1. B型肝炎

  2. C型肝炎

  3. 非アルコール性脂肪性肝炎(NASH)

  4. 腸内細菌

  5. 肝硬変

  6. 肝癌

  7. アミノ酸代謝

Research Areas 1

  1. Life Science / Gastroenterology  / Gastroenterology

Professional Memberships 5

  1. 日本内科学会   支部評議員

    2003.9

  2. 日本消化器病学会   学会評議員

    2017.1

  3. 日本肝臓学会   評議員

    2011.12

  4. 日本消化器内視鏡学会

    2004.12

  5. 日本超音波学会

    2004.1

Committee Memberships 1

  1. 名古屋大学医学部附属病院治験審査委員会   委員  

    2013.10   

Awards 7

  1. The Best Presenter Award in International Session

    2021.11   JDDW2021   Possible prediction of functional cure by HBV core mutations in patients with chronic hepatitis B

     More details

    Award type:Award from Japanese society, conference, symposium, etc. 

  2. Poster of Distinction for presentation

    2020.11   AASLD2020   AMINO ACID POLYMORPHISM IN HEPATITIS B VIRUS ASSOCIATED WITH NATURAL CLEARANCE OF HBV DNA AND HBsAg

     More details

    Award type:Award from international society, conference, symposium, etc. 

  3. ポスター優秀演題賞

    2019.11   JDDW2019   C型肝癌症例に関連する腸内細菌の検討

     More details

    Award type:Award from Japanese society, conference, symposium, etc. 

  4. 冠Award 「第2回Gilead Sciences Award」

    2017.10   日本肝臓学会  

     More details

    Award type:Award from Japanese society, conference, symposium, etc.  Country:Japan

  5. 63th AASLD Presidential Poster of Distinction

    2016.5   American Association for the Study of Liver Diseases  

     More details

    Award type:Award from international society, conference, symposium, etc.  Country:United States

  6. AASLD Presidential Poster of Distinction

    2012.11   American Association for the Study of Liver Diseases  

     More details

    Award type:Award from international society, conference, symposium, etc.  Country:Japan

  7. 日本肝臓学会海外研修スポンサーシップ

    2007.4   社団法人 日本肝臓学会  

     More details

    Award type:Award from Japanese society, conference, symposium, etc.  Country:Japan

▼display all

 

Papers 223

  1. Characteristics of microbiomes of the saliva, duodenal bulb, and descending portion of superficial nonampullary duodenal epithelial tumors Reviewed

    Shibata H, Yamamoto K, Hirose T, Furune S, Kakushima N, Furukawa K, Nakamura M, Honda T*, Fujishiro M, Kawashima H.

    Dig Liver Dis     2024.2

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

  2. *Effects of 1‐kestose on microbiome changes caused by vonoprazan: a randomized, double‐blind, placebo‐controlled pilot study Reviewed

    Furune S, Suzuki T, Honda T*, Yamamoto K, Furukawa K, Nakamura M, Ishigami M, Kinoshita F, Kadota Y, Tochio T, Shimomura Y, Hirooka Y, Fujishiro M, Hirroka Y, Kawashima H

    J Gastroenterol Hepatol.     2023.12

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/jgh.16445.

  3. Monoclonal Antibody Against Mature Interleukin-18 Ameliorates Colitis in Mice and Improves Epithelial Barrier Function Reviewed

    Ikegami S, Maeda K, Urano T, Mu J, Nakamura M, Yamamura T, Sawada T, Ishikawa E, Yamamoto K, Muto H, Oishi A, Iida T, Mizutani Y, Ishikawa T, Kakushima N, Furukawa K, Ohno E, Honda T, Ishigami M, Kawashima H.

    Inflamm Bowel Dis     2023.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1093/ibd/izad292.

  4. *Impact of elobixibat on liver tumors, microbiome, and bile acid levels in a mouse model of nonalcoholic steatohepatitis. Reviewed International journal

    Sugiyama Y, Yamamoto K, Honda T*, Kato A, Muto H, Yokoyama S, Ito T, Imai N, Ishizu Y, Nakamura M, Asano T, Enomoto A, Zaitsu K, Ishigami M, Fujishiro M, Kawashima H

    Hepatology international   Vol. 17 ( 6 ) page: 1378 - 1392   2023.12

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s12072-023-10581-2

    Scopus

    PubMed

  5. A new criterion including the aspartate aminotransferase-to-platelet ratio index and liver and spleen stiffness to rule out varices needing treatment in children with biliary atresia: Modification of the Baveno VII criteria. Reviewed International journal

    Hepatology research : the official journal of the Japan Society of Hepatology     2023.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/hepr.13976

    Scopus

    PubMed

  6. Clinical course and prognosis of patients with hepatocellular carcinoma and haemophilia. Reviewed International journal

    European journal of gastroenterology & hepatology   Vol. 35 ( 10 ) page: 1211 - 1215   2023.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/MEG.0000000000002628

    Scopus

    PubMed

  7. Real-World Effectiveness and Risk Factors for Discontinuation of Ustekinumab in Ulcerative Colitis. Reviewed International journal

    Inflammatory intestinal diseases   Vol. 8 ( 2 ) page: 60 - 68   2023.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1159/000531497

    Scopus

    PubMed

  8. Clinical characteristics of Dieulafoy’s Lesion in the Small Bowel Diagnosed and Treated by Double-Balloon Endoscopy Reviewed

    Nakamura M, Yamamura T, Maeda K, Sawada T, Ishikawa E, Furukawa K, Iida T, Mizutani Y, Yamao K, Ishikawa T, Honda T, Ishigami M, Kawashima H.

    BMC Gastroenterol.   Vol. 23 ( 1 ) page: 290   2023.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s12876-023-02913-1.

  9. Letter: 1-kestose, the smallest fructooligosaccharide component, protection for mild to moderate ulcerative colitis patients-authors' reply. Reviewed International journal

    Alimentary pharmacology & therapeutics   Vol. 57 ( 11 ) page: 1351 - 1352   2023.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/apt.17443

    Scopus

    PubMed

  10. Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis. Reviewed International journal

    Takafumi Yamamoto, Kazuyuki Mizuno, Takanori Ito, Shinya Yokoyama, Kenta Yamamoto, Norihiro Imai, Yoji Ishizu, Takashi Honda, Takuya Ishikawa, Akira Kanamori, Satoshi Yasuda, Hidenori Toyoda, Kenji Yokota, Tetsunari Hase, Naoki Nishio, Osamu Maeda, Makoto Ishii, Michihiko Sone, Yuichi Ando, Masashi Akiyama, Masatoshi Ishigami, Hiroki Kawashima

    Investigational new drugs   Vol. 41 ( 3 ) page: 512 - 521   2023.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Immune-related sclerosing cholangitis (irSC) is relatively rare and its clinical characteristics are not well known. In this study, we aimed to summarize the clinical features of irSC. Clinical data were collected retrospectively from 1,393 patients with advanced malignancy treated with immune-checkpoint inhibitors (ICIs) between August 2014 and October 2021. We analyzed patients with immune-related adverse events of liver injury (liver-irAEs) and compared irSC and non-irSC groups. Sixty-seven patients (4.8%) had a liver-irAE (≥ grade 3) during the follow-up period (median, 262 days). Among these, irSC was observed in eight patients (11.9%). All patients in the irSC group were treated with anti-PD-1/PD-L1 antibodies. Compared with the non-irSC group, the irSC group showed mainly non-hepatocellular liver injury (87.5 % vs 50.8 %, P = 0.065), and had elevated serum inflammatory markers (e.g., CRP and NLR) and biliary enzymes (e.g., GGTP and ALP) at the onset of liver-irAEs. Furthermore, most patients with irSC had abdominal pain. In the non-irSC group, the liver injury of 23 patients improved only with the discontinuation of ICIs, and 22 patients improved with medication including prednisolone (PSL). Conversely, almost all patients (n=7) in the irSC group were treated with PSL, but only two patients experienced an improvement in liver injury. We found that irSC is characterized by a non-hepatocellular type of liver injury with abdominal pain and a high inflammatory response and is refractory to treatment. Further examination by imaging is recommended to detect intractable irSC in cases with these characteristics.

    DOI: 10.1007/s10637-023-01366-3

    Scopus

    PubMed

  11. Pretreatment Proteinuria Predicts the Prognosis of Patients Receiving Systemic Therapy for Unresectable Hepatocellular Carcinoma. Reviewed International journal

    Mizuno K, Imai N, Yamamoto T, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Kuzuya T, Ishigami M, Kawashima H

    Cancers   Vol. 15 ( 10 )   2023.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3390/cancers15102853

    Scopus

    PubMed

  12. Successful Treatment with Steroids in a Patient with Vanishing Bile Duct Syndrome and Acute Tubular Necrosis Reviewed International journal

    Mizuno Fumitaka, Imai Norihiro, Yasuda Kazushi, Yokoyama Shinya, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Honda Takashi, Ishigami Masatoshi, Kawashima Hiroki

    Internal Medicine   Vol. advpub ( 0 )   2023.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:The Japanese Society of Internal Medicine  

    <p>Vanishing bile duct syndrome (VBDS) is a rare but potentially serious cholestatic liver disease caused by various etiologies, including drugs. We herein report a complicated case of VBDS with acute tubular necrosis (ATN) that improved significantly with steroid treatment. An Asian man in his 30s was admitted with the acute onset of severe jaundice and a decline in the renal function. Although initial treatment with ursodeoxycholic acid did not reduce jaundice or renal dysfunction, steroid treatment remarkably improved the VBDS and ATN to within the respective normal ranges. Steroid treatment can be considered in cases of VBDS that appear to have an immune-mediated cause. </p>

    DOI: 10.2169/internalmedicine.1826-23

    PubMed

    CiNii Research

  13. Distinct features of two lipid droplets types in cell nuclei from patients with liver diseases. Reviewed International journal

    Imai N, Ohsaki Y, Cheng J, Zhang J, Mizuno F, Tanaka T, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Ishigami M, Wake H, Kawashima H

    Scientific reports   Vol. 13 ( 1 ) page: 6851   2023.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41598-023-33977-4

    Scopus

    PubMed

  14. *Proteomic Analysis Reveals Changes in Tight Junctions in the Small Intestinal Epithelium of Mice Fed a High-Fat Diet Invited Reviewed

    Muto H, Honda T, Tanaka T, Yokoyama S, Yamamoto K, Ito T, Imai N, Ishizu Y, Maeda K, Ishikawa T, Adachi S, Chikara Sato C, Tsuji M N, Fujishiro M, Kawashima H

    Nutrients   Vol. 15 ( 1473 )   2023.3

     More details

    Authorship:Corresponding author   Language:English  

  15. Accuracy of Serum Leucine-Rich Alpha-2 Glycoprotein in Evaluating Endoscopic Disease Activity in Crohn's Disease. Reviewed International journal

    Inflammatory bowel diseases   Vol. 29 ( 2 ) page: 245 - 253   2023.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1093/ibd/izac076

    Scopus

    PubMed

  16. Endoscopic injection sclerotherapy with polidocanol for cardiac varices in children and adolescents. Reviewed International journal

    Shinya Yokoyama, Yoji Ishizu, Takashi Honda, Norihiro Imai, Takanori Ito, Kenta Yamamoto, Akinari Hinoki, Wataru Sumida, Chiyoe Shirota, Takahisa Tainaka, Satoshi Makita, Kazuki Yokota, Hiroo Uchida, Masatoshi Ishigami

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie   Vol. 30 ( 2 ) page: 109 - 112   2023.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Like esophageal varices, cardiac varices are often treated with endoscopic variceal ligation (EVL). However, we previously reported that EVL for cardiac varices may be associated with a high risk of rebleeding from the ulcer if the O-ring spontaneously drops off early. The efficacy and safety of para-variceal endoscopic injection sclerotherapy (EIS) with polidocanol for the treatment of cardiac varices in children and adolescents were evaluated. METHODS: Eleven patients under 18 years of age with portal hypertension who underwent para-variceal EIS with polidocanol for cardiac varices with red signs, which were considered to be at high risk of bleeding, were retrospectively reviewed. RESULTS: One session of para-variceal polidocanol-EIS was performed for each of the 11 patients. One patient experienced temporary hypoxia due to aspiration of saliva when the tracheal intubation tube was removed after the procedure but recovered by endotracheal suctioning; there were no other adverse events. In six of the eight cases in which efficacy could be evaluated, eradication of cardiac varices was achieved. CONCLUSION: Para-variceal polidocanol-EIS may be considered instead of EVL for small cardiac varices with red signs in pediatric patients with cardiac varices.

    DOI: 10.1016/j.arcped.2022.11.016

    Scopus

    PubMed

  17. Clustering using unsupervised machine learning to stratify the risk of immune-related liver injury. Reviewed International journal

    Yamamoto T, Morooka H, Ito T, Ishigami M, Mizuno K, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Honda T, Yokota K, Hase T, Maeda O, Hashimoto N, Ando Y, Akiyama M, Kawashima H

    Journal of gastroenterology and hepatology   Vol. 38 ( 2 ) page: 251 - 258   2023.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/jgh.16038

    Scopus

    PubMed

  18. Significance of pretreatment alpha-fetoprotein in patients with compensated severe fibrosis after hepatitis C viral eradication. Reviewed International journal

    Ishigami M, Honda T, Ishizu Y, Imai N, Ito T, Yamamoto K, Kawashima H

    Journal of hepato-biliary-pancreatic sciences     2023.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/jhbp.1309

    Scopus

    PubMed

  19. CO(2) enterography in endoscopic retrograde cholangiography using double-balloon endoscopy: A randomized clinical trial. Reviewed International journal

    Journal of gastroenterology and hepatology     2023.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/jgh.16112

    Scopus

    PubMed

  20. *Efficacy of 1-kestose supplementation in patients with mild to moderate ulcerative colitis: A randomised, double-blind, placebo-controlled pilot study. Reviewed International journal

    Shuji Ikegami, Masanao Nakamura, Takashi Honda, Takeshi Yamamura, Keiko Maeda, Tsunaki Sawada, Eri Ishikawa, Kenta Yamamoto, Satoshi Furune, Takuya Ishikawa, Kazuhiro Furukawa, Eizaburo Ohno, Masatoshi Ishigami, Fumie Kinoshita, Yoshihiro Kadota, Takumi Tochio, Yoshiharu Shimomura, Yoshiki Hirooka, Hiroki Kawashima

    Alimentary pharmacology & therapeutics     2023.1

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Ulcerative colitis involves an excessive immune response to intestinal bacteria. Whether administering prebiotic 1-kestose is effective for active ulcerative colitis remains controversial. AIMS: This randomised, double-blind, placebo-controlled pilot trial investigated the efficacy of 1-kestose against active ulcerative colitis. METHODS: Forty patients with mild to moderate active ulcerative colitis were randomly treated with 1-kestose (N = 20) or placebo (maltose, N = 20) orally for 8 weeks in addition to the standard treatment. The Lichtiger clinical activity index and Ulcerative Colitis Endoscopic Index of Severity were determined. Faecal samples were analysed to evaluate the gut microbiome and metabolites. RESULTS: The clinical activity index at week 8 was significantly lower in the 1-kestose group than in the placebo group (3.8 ± 2.7 vs. 5.6 ± 2.1, p = 0.026). Clinical remission and response rates were higher in the 1-kestose group than in the placebo group (remission: 55% vs. 20%, p = 0.048; response: 60% vs. 25%, p = 0.054). The Ulcerative Colitis Endoscopic Index of Severity at week 8 was not significantly different (2.8 ± 1.6 vs. 3.5 ± 1.6, p = 0.145). Faecal analysis showed significantly reduced alpha-diversity in the 1-kestose group, with a decreased relative abundance of several bacteria, including Ruminococcus gnavus group. The short-chain fatty acid levels were not significantly different between the groups. The incidence of adverse events was comparable between the groups. DISCUSSION: Oral 1-kestose is well tolerated and provides clinical improvement for patients with mild to moderate ulcerative colitis through modulation of the gut microbiome.

    DOI: 10.1111/apt.17387

    Scopus

    PubMed

  21. *Astaxanthin Attenuates Nonalcoholic Steatohepatitis with Downregulation of Osteoprotegerin in Ovariectomized Mice Fed Choline-Deficient High-Fat Diet Reviewed International journal

    Meng Zhao, Lingyun Ma, Takashi Honda, Asuka Kato, Taichi Ohshiro, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Norihiro Imai, Yoji Ishizu, Masanao Nakamura, Hiroki Kawashima, Noriko M. Tsuji, Masatoshi Ishigami, Mitsuhiro Fujishiro

    Digestive Diseases and Sciences   Vol. 68 ( 1 ) page: 155 - 163   2023.1

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    DOI: 10.1007/s10620-022-07489-6

    Scopus

    PubMed

    CiNii Research

    Other Link: https://link.springer.com/article/10.1007/s10620-022-07489-6/fulltext.html

  22. Hepatitis B surface antigen reduction is associated with hepatitis B core-specific CD8(+) T cell quality. Reviewed International journal

    Frontiers in immunology   Vol. 14   page: 1257113   2023

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3389/fimmu.2023.1257113

    Scopus

    PubMed

  23. The presence of high-risk varices after sclerotherapy in biliary atresia. Reviewed International journal

    Shinya Yokoyama, Yoji Ishizu, Takashi Honda, Norihiro Imai, Takanori Ito, Kenta Yamamoto, Chiyoe Shirota, Takahisa Tainaka, Wataru Sumida, Satoshi Makita, Aitaro Takimoto, Yoichi Nakagawa, Shunya Takada, Masatoshi Ishigami, Hiroo Uchida, Hiroki Kawashima

    Pediatrics international : official journal of the Japan Pediatric Society     page: e15454   2022.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Esophagogastric varices (EGVs) may develop as a result of portal hypertension in children with biliary atresia (BA). Although endoscopic injection sclerotherapy (EIS) with ethanolamine oleate (EO) is reported useful for children, risk factors associated with the presence of high-risk EGVs after treatment remain unknown. METHODS: The subjects were BA patients under 15 years of age who underwent EO-EIS. We retrospectively reviewed a total of 28 treatment sessions of EGVs with red signs and those larger than F2, which were considered to be at high risk of bleeding. Survival analysis was performed for the presence of high-risk EGVs at the time of follow-up endoscopy as the occurrence of an event. RESULTS: Univariate analysis showed a significantly increased risk of the presence of high-risk EGVs post-EO-EIS in patients with increased liver stiffness (LS) and Mac-2 binding protein glycan isomer (M2BPGi), with hazard ratios of 1.48 and 1.15, respectively. The median presence-free period was significantly shorter in the LS ≥ 2.8 m/sec patients than in those with LS < 2.8 m/sec (189 vs. 266 days). Similarly, the median presence-free period was significantly shorter in patients with M2BPGi ≥ 4.0 than in those with M2BPGi < 4.0 (182 vs. 203 days). The results of multivariate analysis revealed that the risk of the presence of high-risk EGVs was significantly higher only in the high-LS group, with a hazard ratio of 2.76. CONCLUSIONS: Increased LS is associated with risk of the presence of high-risk EGVs following EO-EIS in children with BA. (246 words).

    DOI: 10.1111/ped.15454

    PubMed

  24. Pipeline Esophagogastric Varices Secondary to Extrahepatic Portal Vein Obstruction Treated Endoscopically with the Assistance of Transileocolic Obliteration Reviewed International journal

    Yokoyama Shinya, Ishizu Yoji, Honda Takashi, Imai Norihiro, Ito Takanori, Yamamoto Kenta, Komada Tomohiro, Hayashi Masamichi, Ishigami Masatoshi

    Internal Medicine   Vol. 61 ( 23 ) page: 3503 - 3511   2022.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:The Japanese Society of Internal Medicine  

    <p>Endoscopic injection sclerotherapy (EIS) for esophagogastric varices (EGV) was attempted for a 29-year-old man with extrahepatic portal vein obstruction. However, pipeline varices characterized by a large blood flow volume were present, and the sclerosant did not accumulate sufficiently in them. Transileocolic obliteration (TIO) using coils was performed, but some EGVs and palisading veins remained. Thus, EIS was performed once again immediately after TIO. Since a reduction in the intravariceal blood flow was achieved by preceding TIO, effective injection of sclerosant into the vessels was possible. For pipeline varices difficult to treat endoscopically, combination therapy with TIO may be effective. </p>

    DOI: 10.2169/internalmedicine.9404-22

    Scopus

    PubMed

    CiNii Research

  25. The effects of ustekinumab on small intestinal lesions and stenotic lesions. Reviewed International journal

    Nagoya journal of medical science   Vol. 84 ( 4 ) page: 825 - 838   2022.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.18999/nagjms.84.4.825

    Scopus

    PubMed

  26. Factors associated with the progression of myosteatosis in patients with cirrhosis. Reviewed International journal

    Ishizu Y, Ishigami M, Honda T, Imai N, Ito T, Yamamoto K, Yokoyama S, Ishikawa T, Fujishiro M

    Hepatology research : the official journal of the Japan Society of Hepatology   Vol. 103-104   page: 111777   2022.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.nut.2022.111777

    Scopus

    PubMed

  27. Effect of illness uncertainty on alanine transaminase levels and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease Reviewed International journal

    Naoki Ozawa, Kazuki Sato, Ayumi Sugimura, Shigeyoshi Maki, Taku Tanaka, Kenta Yamamoto, Takanori Ito, Yoji Ishizu, Teiji Kuzuya, Takashi Honda, Masatoshi Ishigami, Mitsuhiro Fujishiro, Tetsuya Ishikawa, Shoko Ando

    NAGOYA JOURNAL OF MEDICAL SCIENCE   Vol. 84 ( 4 ) page: 857 - 864   2022.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NAGOYA UNIV, SCH MED  

    Patients with nonalcoholic fatty liver disease (NAFLD) have illness uncertainty. The purpose of this longitudinal study was to investigate the effect of the degree of illness uncertainty in patients with NAFLD on liver function values. We conducted a questionnaire survey and collected blood samples from outpatients with NAFLD. The items in the questionnaire were measured for illness uncertainty using the Japanese version of the Mishel Uncertainty in Illness Scale-Community (MUIS-C). Blood samples were collected at baseline and after 1 year. We divided the patients into two groups: one with high illness uncertainty and the other with low illness uncertainty. We then compared changes in alanine transaminase (ALT) and aspartate aminotransferase (AST) levels over time from baseline using multiple regression analysis. This study analyzed 148 patients with NAFLD; 75 were male and 73 were female, with a mean age of 58.4 +/- 12.3 years. The group with higher illness uncertainty had significantly higher ALT and AST levels at 1 year (b = .185 and .183, respectively) than the group with lower illness uncertainty. High illness uncertainty in patients with NAFLD can lead to higher ALT and AST levels. Healthcare providers must focus on reducing illness uncertainty in patients with NAFLD.

    DOI: 10.18999/nagjms.84.4.857

    Web of Science

    Scopus

    PubMed

  28. Decreased appetite is associated with the presence of sarcopenia in patients with cirrhosis. Reviewed International journal

    Ishizu Y, Ishigami M, Honda T, Imai N, Ito T, Yamamoto K, Yokoyama S, Ishikawa T, Kawashima H

    Nutrition (Burbank, Los Angeles County, Calif.)   Vol. 103-104   page: 111807   2022.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.nut.2022.111807

    Scopus

    PubMed

  29. Analysis of immunologic comorbidities in ulcerative colitis patients: a tool to prevent exacerbations in ulcerative colitis cases. Reviewed International journal

    Nagoya journal of medical science   Vol. 84 ( 4 ) page: 733 - 745   2022.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.18999/nagjms.84.4.733

    Scopus

    PubMed

  30. An improved method to assess skeletal muscle mass in patients with liver cirrhosis based on computed tomography images. Reviewed International journal

    Ishizu Y, Ishigami M, Honda T, Imai N, Ito T, Yamamoto K, Yokoyama S, Ishikawa T, Kawashima H

    Hepatology research : the official journal of the Japan Society of Hepatology   Vol. 52 ( 11 ) page: 937 - 946   2022.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/hepr.13820

    Scopus

    PubMed

  31. Effectiveness of Porous Glass Membrane Pumping Emulsification Device in Transarterial Chemoembolization for Solitary Hepatocellular Carcinoma. Reviewed International journal

    Imai N, Ishigami M, Oie Y, Kumagai M, Inukai Y, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Kawashima H

    Anticancer research   Vol. 42 ( 8 ) page: 3947 - 3951   2022.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.21873/anticanres.15889

    Scopus

    PubMed

  32. Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan. Reviewed International journal

    Hamazaki M, Sawada T, Yamamura T, Maeda K, Mizutani Y, Ishikawa E, Furune S, Yamamoto K, Ishikawa T, Kakushima N, Furukawa K, Ohno E, Honda T, Kawashima H, Ishigami M, Nakamura M, Fujishiro M

    BMC gastroenterology   Vol. 22 ( 1 ) page: 342   2022.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s12876-022-02408-5

    Scopus

    PubMed

  33. Endoscopic sphincterotomy and endoscopic biliary stenting do not affect the sensitivity of transpapillary forceps biopsy for the diagnosis of bile duct adenocarcinoma. Reviewed International journal

    BMC gastroenterology   Vol. 22 ( 1 ) page: 329   2022.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s12876-022-02402-x

    Scopus

    PubMed

  34. A case of antiprogrammed death-ligand 1 antibody-induced multisystem immune-related adverse events with pancreatitis and steroid-resistant sclerosing cholangitis. Reviewed International journal

    Journal of digestive diseases   Vol. 23 ( 7 ) page: 404 - 409   2022.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/1751-2980.13122

    Scopus

    PubMed

  35. Gelsolin as a Potential Biomarker for Endoscopic Activity and Mucosal Healing in Ulcerative Colitis. Reviewed International journal

    Maeda Keiko

    Biomedicines   Vol. 10 ( 4 )   2022.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The therapeutic goal in ulcerative colitis is mucosal healing, which requires improved non-invasive biomarkers to evaluate disease activity. Gelsolin is associated with several autoimmune diseases, and here, we aimed to analyze its usefulness as a serological biomarker for clinical and endoscopic activities in ulcerative colitis. Patients with ulcerative colitis (n = 138) who had undergone blood tests and colonoscopy were included. Serum gelsolin was measured using enzyme-linked immunosorbent assay, and correlation between the gelsolin level and clinical and endoscopic activities was examined. The serum gelsolin level in patients with ulcerative colitis was significantly lower than that in healthy subjects, and it decreased in proportion to increasing Mayo score and Mayo endoscopic subscore. The area under the curve for correlation between clinical and endoscopic remission and serum gelsolin level was higher than that for C-reactive protein. Furthermore, in C-reactive protein-negative patients, the serum gelsolin level was lower in the active phase than in remission. Our findings indicate that the serum gelsolin level correlates with clinical and endoscopic activities in ulcerative colitis, has a higher sensitivity and specificity than C-reactive protein, and can detect mucosal healing, suggesting that gelsolin can be used as a biomarker for ulcerative colitis.

    DOI: 10.3390/biomedicines10040872

    Scopus

    PubMed

    CiNii Research

  36. *Differences in the intestinal microbiome associated with diarrhea during lenvatinib treatment for hepatocellular carcinoma Reviewed International journal

    Inukai Y, Yamamoto K, Honda T*, Ito T, Imai N, Ishizu Y, Nakamura M, Kawashima H, Ishigami M.

    Dig Dis.     2022.3

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

  37. Changes in Body Composition Predict the Time to Treatment Failure of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma: A Pilot Retrospective Study. Reviewed International journal

    Nutrition and cancer     page: 1 - 10   2022.3

     More details

    Language:English  

    DOI: 10.1080/01635581.2022.2049322

    PubMed

  38. *Patients with low muscle mass have characteristic microbiome with low potential for amino acid synthesis in chronic liver disease. Reviewed International journal

    Yamamoto K, Ishizu Y, Honda T*, Ito T, Imai N, Nakamura M, Kawashima H, Kitaura Y, Ishigami M, Fujishiro M

    Scientific reports   Vol. 12 ( 1 ) page: 3674   2022.3

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41598-022-07810-3

    Scopus

    PubMed

  39. Network Analysis of Gut Microbiota Including Fusobacterium and Oral Origin Bacteria and Their Distribution on Tumor Surface, Normal Mucosa, and in Feces in Patients with Colorectal Cancer. Reviewed International journal

    Ohashi A, Yamamura T, Nakamura M, Maeda K, Sawada T, Ishikawa E, Yamamoto K, Ishikawa T, Kakushima N, Furukawa K, Ohno E, Honda T, Kawashima H, Ishigami M, Fujishiro M

    Digestion   Vol. 103 ( 6 ) page: 451 - 461   2022

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1159/000527170

    Scopus

    PubMed

  40. Comparison of Endoscopic Ultrasonography and Conventional Endoscopy for Prediction of Tumor Depth in Superficial Nonampullary Duodenal Epithelial Tumors. Reviewed International journal

    Matsuda N, Hirose T, Kakushima N, Furukawa K, Furune S, Ishikawa E, Sawada T, Maeda K, Yamamura T, Ishikawa T, Ohno E, Nakamura M, Honda T, Ishigami M, Kawashima H, Fujishiro M

    Digestion   Vol. 103 ( 4 ) page: 319 - 328   2022

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1159/000524841

    Scopus

    PubMed

  41. *Changes in the gut microbiota after hepatitis C virus eradication Reviewed International journal

    Honda T, Ishigami M, Yamamoto K, Takeyama T, Ito T, Ishizu, Y, Kuzuya T, Nakamura M, Kawashima H, Miyahara R, Tetsuya T, Yoshiki Hirooka Y, Fujishiro M

    Scientific Reports     2021.12

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  42. *Changes in the gut microbiome in relation to the degree of gastric mucosal atrophy before and after <i>Helicobacter pylori</i> eradication. Reviewed International journal

    Furune S, Yamamoto K, Honda T*, Fujiyoshi T, Kakushima N, Furukawa K, Ohno E, Nakamura M, Miyahara R, Kawashima H, Ishigami M, Hirooka Y, Fujishiro M

    Scandinavian journal of gastroenterology     page: 1 - 8   2021.11

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1080/00365521.2021.2005135

    Scopus

    PubMed

  43. *Microbiome, fibrosis and tumor networks in a non-alcoholic steatohepatitis model of a choline-deficient high-fat diet using diethylnitrosamine. Reviewed International journal

    Yamamoto K, Honda T*, Yokoyama S, Ma L, Kato A, Ito T, Ishizu Y, Kuzuya T, Nakamura M, Kawashima H, Ishigami M, Tsuji NM, Fujishiro M

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   Vol. 53 ( 11 ) page: 1443 - 1450   2021.11

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.dld.2021.02.013

    Scopus

    PubMed

  44. *Amino Acid Polymorphism in Hepatitis B Virus Associated With Functional Cure. Reviewed International journal

    Honda T, Yamada N, Murayama A, Shiina M, Aly HH, Kato A, Ito T, Ishizu Y, Kuzuya T, Ishigami M, Murakami Y, Tanaka T, Moriishi K, Nishitsuji H, Shimotohno K, Ishikawa T, Fujishiro M, Muramatsu M, Wakita T, Kato T

    Cellular and molecular gastroenterology and hepatology   Vol. 12 ( 5 ) page: 1583 - 1598   2021.8

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.jcmgh.2021.07.013

    Scopus

    PubMed

  45. *The relationship between oral-origin bacteria in the fecal microbiome and albumin-bilirubin grade in patients with hepatitis C. Reviewed International journal

    Yamamoto K, Honda T*, Ito T, Ishizu Y, Kuzuya T, Nakamura M, Miyahara R, Kawashima H, Ishigami M, Fujishiro M

    Journal of gastroenterology and hepatology   Vol. 36 ( 3 ) page: 790 - 799   2021.3

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/jgh.15206

    Web of Science

    Scopus

    PubMed

  46. *Influence of proton pump inhibitors on microbiota in chronic liver disease patients Reviewed International journal

    Yamamoto K, Ishigami M, Honda T, Takeyama T, Ito T, Ishizu Y, Kuzuya T, Hayashi K, Goto H, Hirooka Y.

    Hepatology International   Vol. 13 ( 2 ) page: 234-244   2019.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  47. *Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice. Reviewed International journal

    Honda T, Ishigami M, Luo F, Lingyun M, Ishizu Y, Kuzuya T, Hayashi K, Nakano I, Ishikawa T, Feng GG, Katano Y, Kohama T, Kitaura Y, Shimomura Y, Goto H, Hirooka Y.

    Metabolism.   Vol. 69   page: 177-187   2017

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  48. *The Core I97L mutation in conjunction with P79Q is associated with persistent low HBVDNA and HBs antigen clearance in chronic hepatitis B patients Reviewed International journal

    Honda T, Ishigami M, Ishizu Y1, Kuzuya T, Hayashi K, Ishikawa T, Murakami Y, Iwadate M, Umeyama H, Toyoda H, Kumada T, Katano Y, Goto H, Hirooka Y.

    Clin Microbiol Infect.   Vol. 23 ( 407 ) page: e1-e7   2016.12

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  49. *Effect of Peginterferon alfa-2b and Ribavirin on Hepatocellular Carcinoma Prevention in Older Patients with Chronic Hepatitis C Reviewed International journal

    Honda T, Ishigami M, Hayashi H, Ishizu Y, Kuzuya T, Hayashi K, Itoh A, Hirooka Y, Nakano I, Ishikawa T, Urano F, Yoshioka K, Toyoda H, Kumada T, Katano Y, Goto H.

    J Gastroenterol Hepatol   Vol. 30 ( 2 ) page: 321 - 328   2015.2

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/jgh.12703

    Web of Science

    PubMed

  50. *Comparison of the efficacy of ribavirin plus peginterferon alfa-2b for chronic hepatitis C infection in patients with and without coagulation disorders Reviewed International journal

    Honda T, Katano Y, Kuzuya T, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Nakano I, Ishikawa T, Toyoda H, Kumada T, Yamamoto K, Matsushita T, Kojima T, Takamatsu J, Goto H.

    J Med Virol.   Vol. 85 ( 2 ) page: 228 - 234   2013.2

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  51. *Efficacy of peginterferon-alpha-2b plus ribavirin in patients aged 65 years andolder with chronic hepatitis C. Reviewed International journal

    Honda T, Katano Y, Shimizu J, Ishizu Y, Doizaki M, Hayashi K, Ishigami M,Itoh A, Hirooka Y, Nakano I, Urano F, Yoshioka K, Toyoda H, Kumada T, Goto H.

    Liver Int.   Vol. 30 ( 4 ) page: 527 - 537   2010.4

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/j.1478-3231.2009.02064.x

  52. *Efficacy of ribavirin plus Efficacy of ribavirin plus interferon-α in patients aged >or=60 years with chronic hepatitis C. Reviewed International journal

    Honda T, Katano Y, Urano F, Murayama M, Hayashi K, Ishigami M, Nakano I, Yoshioka K, Toyoda H, Kumada T, Goto H

    J Gastroenterol Hepatol.   Vol. 22 ( 7 ) page: 989 - 995   2007.7

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/j.1440-1746.2006.04773.x

  53. *Ribavirin and use of clotting factors in patients with hemophilia and chronic hepatitis C Reviewed International journal

    Honda T, Toyoda H, Hayashi K, Katano Y, Yano M, Nakano I, Yoshioka K, Goto H, Yamamoto K, Takamatsu J

    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION   Vol. 293 ( 10 ) page: 1190 - 1192   2005.3

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    Web of Science

  54. *Effects of liver failure on branched-chain alpha-keto acid dehydrogenase complex in rat liver and muscle: comparison between acute and chronic liver failure Reviewed International journal

    Honda T, Fukuda Y, Nakano I, Katano Y, Goto H, Nagasaki M, Sato Y, Murakami T, Shimomura Y.

    J Hepatol.   Vol. 40 ( 3 ) page: 439 - 445   2004.3

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.jhep.2003.11.003

  55. The impact of the age-adjusted Charlson comorbidity index as a prognostic factor for endoscopic papillectomy in ampullary tumors. Reviewed International journal

    Takada Y, Kawashima H, Ohno E, Ishikawa T, Mizutani Y, Iida T, Yamamura T, Kakushima N, Furukawa K, Nakamura M, Honda T, Ishigami M, Ito A, Hirooka Y

    Journal of gastroenterology   Vol. 57 ( 3 ) page: 199 - 207   2022.3

     More details

    Language:English   Publisher:Journal of Gastroenterology  

    Background: The prognostic nutritional index (PNI) and Charlson comorbidity index (CCI) have been useful for predicting the prognosis based on nutritional condition and comorbidities in surgery and endoscopic mucosal dissection. The age-adjusted CCI (ACCI) has also been reported to be useful in surgery, but it has not been applied to endoscopic treatment. We therefore clarified the prognostic factors associated with ampullary tumors treated with endoscopic papillectomy (EP). Methods: From January 2003 to December 2020, 236 patients who underwent EP for sporadic ampullary tumors at Nagoya University Hospital were included in this study. The 5-year survival and ability to predict the prognosis were evaluated in terms of the sex, PNI, ACCI, final pathological diagnosis, and intraductal extension. Results: During a median follow-up period of 1558 days, 17 patients died. No patient died of the primary disease. The 5-year survival rate was 91.1%. In a univariate analysis, only a high ACCI (≥ 5) was extracted as a significant prognostic factor (Odds ratio, 12.2; 95% confidence interval, 3.81–39.3; p < 0.001). The 5-year survival rates for a low ACCI (≤ 4) and high ACCI were 96.6% and 73.5%, respectively (p < 0.001). Conclusions: A high ACCI is an important prognostic factor associated with the 5-year survival and a risk of death from other illness. Ampullary tumors suitable for EP are less likely to be a prognostic factor, and treatment-free follow-up may be acceptable in patients with a high ACCI.

    DOI: 10.1007/s00535-022-01853-z

    Scopus

    PubMed

  56. Multiple cancer type classification by small RNA expression profiles with plasma samples from multiple facilities Reviewed

    Suzuki K., Igata H., Honda T., Kawashima H., Ishigami M., Abe M., Yamamoto Y.

    Cancer Science     2022.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  57. Preliminary Comparison of Endoscopic Brush and Net Catheters as the Sampling Tool to Analyze the Intestinal Mucus in the Rectum with Ulcerative Colitis Patients. International journal

    Nakamura M, Maeda K, Yamamoto K, Yamamura T, Sawada T, Ishikawa E, Kakushima N, Furukawa K, Iida T, Mizutani Y, Ishikawa T, Ohno E, Honda T, Ishigami M, Kawashima H

    Digestion     page: 1 - 12   2022.2

     More details

    Language:English   Publisher:Digestion  

    Background: The pathophysiology of ulcerative colitis (UC) remains unclear, but early lesions on the colorectal mucosal surface may play an important role in its etiology. Intestinal mucus samples, including inner and outer layers, are collected by net or brush catheters, but the quality of the samples obtained by each method has not been fully investigated. Objective: The purpose of this study was to compare the microbiome and protein content of intestinal mucus collected by net and brush catheters during colonoscopy. Methods: Intestinal mucus samples from the lower rectum of 4 patients with UC were collected using a net catheter, a brush catheter, and intestinal fluid suction. Microbiome and protein content were analyzed using 16S rRNA gene sequencing and mass spectrometry. Results: The patients demonstrated significant differences in microbiome alpha diversity (p < 0.05), but this difference was not observed between the sampling methods. Net catheter samples demonstrated higher total protein concentrations than brush catheter samples. The brush catheter group had more Lachnospira, a butyrate-producing bacterium, when compared to the net group. The brush catheter group also had more oral bacteria of Staphylococcus and Dialister in those with active phase when compared to the net group. Conclusions: Brush catheters are more likely to collect the intestinal mucus inner layer, whereas net catheters are more likely to collect larger samples that include the outer mucus layer, as well as the intestinal fluid. Two sampling methods with different types of collection of the mucosa may lead to different results among patients with mucosal vulnerabilities.

    DOI: 10.1159/000521929

    Scopus

    PubMed

  58. Immunoproliferative Small Intestinal Disease Diagnosed by Double-balloon Endoscopy with Biopsy Sampling Reviewed International journal

    Meza Miguel Ricardo Rodríguez, Nakamura Masanao, Yamamura Takeshi, Maeda Keiko, Sawada Tsunaki, Ishikawa Eri, Kakushima Naomi, Furukawa Kazuhiro, Ohno Eizaburo, Honda Takashi, Kawashima Hiroki, Ishigami Masatoshi

    Internal Medicine   Vol. advpub ( 0 )   2022.2

     More details

    Language:English   Publisher:The Japanese Society of Internal Medicine  

    <p>We herein report an 80-year-old man diagnosed with immunoproliferative small intestine disease (IPSID) via small bowel endoscopy with a biopsy. He developed persistent diarrhea and subsequently presented with hypoproteinemia and moderate anemia. Transanal double-balloon endoscopy showed prominent villous edema in the middle and lower ileum, while a histological examination showed high lymphocyte/plasma cell infiltration in the mucosal layer. Furthermore, an immunostaining analysis showed that CD3 and CD20 were partially positive, while CD138 was diffusely positive. Immunoglobulin A positivity was also observed. He was diagnosed with IPSID and received a nutritional agent and minocycline. After three months, the patients' symptoms improved. </p>

    DOI: 10.2169/internalmedicine.8847-21

    PubMed

  59. Factors related to delayed adverse events of endoscopic submucosal dissection in the duodenum. Reviewed International journal

    Kawamura T, Hirose T, Kakushima N, Furukawa K, Furune S, Ishikawa E, Sawada T, Maeda K, Yamamura T, Ishikawa T, Ohno E, Nakamura M, Honda T, Ishigami M, Kawashima H, Fujishiro M

    Digestive diseases (Basel, Switzerland)     2022.2

     More details

    Language:English  

    DOI: 10.1159/000522362

    PubMed

  60. Comparison of outcomes between secondary fully covered and uncovered self-expandable metal stents in the treatment of recurrent biliary obstruction of pancreatic cancer. Reviewed International journal

    Kataoka K, Kawashima H, Ohno E, Ishikawa T, Mizutani Y, Iida T, Furukawa K, Nakamura M, Honda T, Ishigami M, Fujishiro M

    Surgical endoscopy     2022.1

     More details

    Language:English   Publisher:Surgical Endoscopy  

    Background: The overall survival (OS) of pancreatic cancer (PC) has been prolonged by advances in chemotherapy, and the number of cases of recurrent biliary obstruction (RBO) after self-expandable metal stent (SEMS) placement is expected to increase. We herein compared outcomes between secondary fully covered SEMS (FC) and uncovered SEMS (UC) for RBO of PC with FC placed as the 1st SEMS. Methods: Between May 2010 and March 2021, 62 PC patients who underwent SEMS exchange to FC (n = 34) or UC (n = 28) for RBO were retrospectively analyzed. Patient characteristics, OS, time to RBO (TRBO), and stent-related adverse events were compared between the FC and UC groups. Cox’s proportional hazard model was used to identify risk factors for RBO with the 2nd SEMS. Results: There was a significant difference between the FC and UC groups only in the 2nd SEMS diameter. Median OS and TRBO were 195 and 238 days in FC patients and 306 and 455 days in UC patients, respectively, with no significant differences between the two groups. No significant differences were observed in the stent-related adverse event rate. In multivariate analyses, only the 2nd SEMS diameter was significant (P = 0.009). Median TRBO were 455, 238, and 103 days in 10-mm UC, 10-mm FC, and 8-mm UC patients, with 10-mm UC patients having significantly longer TRBO than 10-mm FC and 8-mm UC patients (P = 0.020 and 0.001). Conclusion: SEMS exchange to 10-mm UC may be appropriate for RBO of PC with FC as the 1st SEMS.

    DOI: 10.1007/s00464-021-08981-2

    Scopus

    PubMed

  61. Differentiation Between Solid Pseudopapillary Neoplasm of the Pancreas and Nonfunctional Pancreatic Neuroendocrine Neoplasm Using Endoscopic Ultrasound. Reviewed International journal

    Kataoka K, Ishikawa T, Ohno E, Mizutani Y, Iida T, Furukawa K, Nakamura M, Honda T, Ishigami M, Kawashima H, Hirooka Y, Fujishiro M

    Pancreas   Vol. 51 ( 1 ) page: 106 - 111   2022.1

     More details

    Language:English   Publisher:Pancreas  

    Objectives We investigated the utility of endoscopic ultrasound (EUS) for differentiating between solid pseudopapillary neoplasm of the pancreas (SPN) and pancreatic neuroendocrine neoplasm (PanNEN). Methods A retrospective analysis was performed on 29 and 77 consecutive patients with pathologically proven SPN and nonfunctional PanNEN. In patients who underwent contrast-enhanced harmonic EUS (CH-EUS), lesions were classified into 3 vascular patterns (hypoechoic/isoechoic/hyperechoic), and the presence of "the alveolus nest sign,"which we previously reported as a characteristic feature of SPN on CH-EUS, was also assessed. Results Conventional EUS findings showed that calcification echoes were significantly more frequent in SPN lesions than in PanNEN lesions (19/29 [66%] vs 21/77 [27%], P = 0.001) as was internal isoechogenicity or hyperechogenicity (10/29 [34%] vs 11/77 [14%], P = 0.029). Contrast-enhanced harmonic EUS findings showed that SPN lesions more frequently had the isoechoic or hypoechoic vascular pattern, and significantly more frequently had the alveolus nest sign (18/25 [72%] vs 4/60 [7%], P < 0.001). In a multivariate analysis, the presence of the alveolus nest sign contributed the most to the SPN diagnosis (odds ratio, 70; 95% confidence interval, 6.2-786). Conclusions Endoscopic ultrasound, particularly the presence of the alveolus nest sign on CH-EUS, is useful for differentiating SPN from PanNEN.

    DOI: 10.1097/MPA.0000000000001966

    Scopus

    PubMed

  62. The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophilia HCC after HCV eradication in hemophilia Reviewed International journal

    Inukai Yosuke, Imai Norihiro, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Honda Takashi, Okamoto Shuichi, Kanematsu Takeshi, Suzuki Nobuaki, Matsushita Tadashi, Ishigami Masatoshi, Fujishiro Mitsuhiro

    ANNALS OF HEPATOLOGY   Vol. 27 ( 1 ) page: 100545   2022

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.aohep.2021.100545

    Web of Science

    Scopus

    PubMed

  63. Initial experience of tofacitinib for treating refractory moderate-to-severe ulcerative colitis Reviewed International journal

    Nakamura M., Yamamura T., Maeda K., Sawada T., Mizutani Y., Ishikawa E., Ishikawa T., Kakushima N., Furukawa K., Ohno E., Kawashima H., Honda T., Ishigami M., Fujishiro M.

    Nagoya Journal of Medical Science   Vol. 84 ( 1 ) page: 169 - 179   2022

     More details

    Language:Japanese   Publisher:Nagoya Journal of Medical Science  

    Ulcerative colitis (UC) is an incurable, chronic inflammatory disease of the large bowel whose etiology and pathogenesis have not yet been comprehensively explained. Tofacitinib is a small molecule Janus kinase inhibitor that was introduced for treating refractory UC. We aimed to examine the efficacy and safety of tofacitinib for the treatment of 18 patients with UC. Continuous treatment rates were 50, 38, and 33% at 8, 24, and 52 weeks, respectively. Overall, 83.3% of these patients showed tumor necrosis factor (TNF) antibody failure status. When the effective status was defined as a Lichtiger index (LI) that decreased by 3 points or more or was less than 4 points and remission status was defined as an LI less than 4 points, the effective and remission rates (%) at 2, 8, and 16 weeks were 55.5 (10/18) and 22.2 (4/18), 38.8 (7/18) and 33.3 (6/18), and 38.8 (7/18) and 38.8 (7/18), respectively. Background characteristics of 2-week responders and non-responders were compared. C-reactive protein level in responders was significantly lower than that in non-responders, and the hemoglobin level in responders was significantly higher than that in non-responders. This study provides preliminary results of the effectiveness of tofacitinib even for TNF antibody and tacrolimus failure patients.

    DOI: 10.18999/nagjms.84.1.169

    Scopus

  64. Obesity and myosteatosis: the two characteristics of dynapenia in patients with cirrhosis. Reviewed International journal

    Sugiyama Y, Ishizu Y, Ando Y, Yokoyama S, Yamamoto K, Ito T, Imai N, Nakamura M, Honda T, Kawashima H, Ishikawa T, Ishigami M

    European journal of gastroenterology & hepatology   Vol. 33 ( 1S Suppl 1 ) page: e916 - e921   2021.12

     More details

    Language:English   Publisher:European journal of gastroenterology &amp; hepatology  

    OBJECTIVE: In patients with liver cirrhosis, the clinical characteristics of dynapenia, a condition in which skeletal muscle mass is maintained but muscle strength is reduced, are not yet known. This study aimed to clarify the characteristics of dynapenia and its impact on quality of life (QOL) in patients with liver cirrhosis. METHODS: We retrospectively analyzed 116 patients with cirrhosis. Based on grip strength and skeletal muscle mass measured by the bioelectrical impedance analysis method, patients were divided into four groups: normal muscle status, dynapenia, pre-sarcopenia (a condition involving only low muscle mass), and sarcopenia. The characteristics of dynapenia and its influence on QOL were examined. RESULTS: Fourteen patients had dynapenia. Liver function did not differ among the four groups. In patients with dynapenia, BMI was highest and computed tomography attenuation of skeletal muscle at the third lumbar spine vertebra was lowest among the four groups. The percentage of patients with both BMI ≥25 kg/m2 and myosteatosis was significantly higher in patients with dynapenia [9/14 (64.3%)] than in those with sarcopenia [2/23 (8.7%), P = 0.004] and pre-sarcopenia [0/18 (0%), P < 0.001] and tended to be higher than those with normal muscle status [16/61 (26.2%), P = 0.065]. The physical QOL in patients with dynapenia was as low as that in those with sarcopenia and significantly lower than that in those with normal muscle status. CONCLUSION: Cirrhotic patients with dynapenia had high BMI and myosteatosis, and impaired physical QOL.

    DOI: 10.1097/MEG.0000000000002303

    Scopus

    PubMed

  65. Immune-related Liver Injury is a Poor Prognostic Factor in Patients with Nonsmall Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Reviewed International journal

    Yamamoto T, Ito T, Hase T, Ishigami M, Mizuno K, Yamamoto K, Imai N, Ishizu Y, Honda T, Shibata H, Hatta T, Yogo N, Yasuda S, Toyoda H, Abe T, Kawashima H, Hashimoto N, Fujishiro M

    Cancer investigation     page: 1 - 10   2021.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1080/07357907.2021.1994586

    Scopus

    PubMed

  66. Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival Reviewed International journal

    Yamada K., Nakamura M., Yamamura T., Ishikawa E., Iida T., Mizutani Y., Kakushima N., Ishikawa T., Furukawa K., Ohno E., Honda T., Ishigami M., Sawada T., Maeda K., Kawashima H., Furune S., Maeda O., Ando Y., Hase T., Hashimoto N., Yokota K., Akiyama M., Fujishiro M.

    World Journal of Gastroenterology   Vol. 27 ( 41 ) page: 7190 - 7206   2021.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3748/wjg.v27.i41.7190

    Scopus

  67. Safety and Efficacy of Glass Membrane Pumping Emulsification Device in Transarterial Chemoembolization for Hepatocellular Carcinoma: First Clinical Outcomes. Reviewed International journal

    Imai N, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Ishigami M

    Anticancer research   Vol. 41 ( 11 ) page: 5817 - 5820   2021.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.21873/anticanres.15399

    Scopus

    PubMed

  68. Absence of large portal collateral vessels is concerned with spontaneous improvement of cirrhotic portal vein thrombosis. Reviewed International journal

    Yokoyama S, Ishizu Y, Honda T, Imai N, Ito T, Yamamoto K, Tomoyuki T, Ishigami M

    Hepatology research : the official journal of the Japan Society of Hepatology     2021.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/hepr.13725

    PubMed

  69. Basigin deficiency prevents anaplerosis and ameliorates insulin resistance and hepatosteatosis Reviewed International journal

    Ryuge Akihiro, Kosugi Tomoki, Maeda Kayaho, Banno Ryoichi, Gou Yang, Zaitsu Kei, Ito Takanori, Sato Yuka, Hirayama Akiyoshi, Tsubota Shoma, Honda Takashi, Nakajima Kazuki, Ozaki Tomoya, Kondoh Kunio, Takahashi Kazuo, Kato Noritoshi, Ishimoto Takuji, Soga Tomoyoshi, Nakagawa Takahiko, Koike Teruhiko, Arima Hiroshi, Yuzawa Yukio, Minokoshi Yasuhiko, Maruyama Shoichi, Kadomatsu Kenji

    JCI INSIGHT   Vol. 6 ( 20 )   2021.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1172/jci.insight.142464

    Web of Science

    Scopus

    PubMed

  70. Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies Reviewed International journal

    Ito Takanori, Ishigami Masatoshi, Yamamoto Takafumi, Mizuno Kazuyuki, Yamamoto Kenta, Imai Norihiro, Ishizu Yoji, Honda Takashi, Kawashima Hiroki, Yasuda Satoshi, Toyoda Hidenori, Yokota Kenji, Hase Tetsunari, Nishio Naoki, Maeda Osamu, Kato Masashi, Hashimoto Naozumi, Hibi Hideharu, Kodera Yasuhiro, Sone Michihiko, Ando Yuichi, Akiyama Masashi, Shimoyama Yoshie, Fujishiro Mitsuhiro

    HEPATOLOGY INTERNATIONAL   Vol. 15 ( 5 ) page: 1278 - 1287   2021.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s12072-021-10238-y

    Web of Science

    Scopus

    PubMed

  71. Factors associated with bleeding after endoscopic variceal ligation in children Reviewed International journal

    Yokoyama Shinya, Ishizu Yoji, Ishigami Masatoshi, Honda Takashi, Kuzuya Teiji, Ito Takanori, Hinoki Akinari, Sumida Wataru, Shirota Chiyoe, Tainaka Takahisa, Makita Satoshi, Yokota Kazuki, Uchida Hiroo, Fujishiro Mitsuhiro

    PEDIATRICS INTERNATIONAL   Vol. 63 ( 10 ) page: 1223 - 1229   2021.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/ped.14614

    Web of Science

    Scopus

    PubMed

  72. Differentiation between pancreatic metastases from renal cell carcinoma and pancreatic neuroendocrine neoplasm using endoscopic ultrasound. Reviewed International journal

    Kataoka K, Ishikawa T, Ohno E, Mizutani Y, Iida T, Ishikawa E, Furukawa K, Nakamura M, Honda T, Ishigami M, Kawashima H, Hirooka Y, Fujishiro M

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]   Vol. 21 ( 7 ) page: 1364 - 1370   2021.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.pan.2021.07.001

    Scopus

    PubMed

  73. Conditioned medium from stem cells derived from human exfoliated deciduous teeth ameliorates NASH via the Gut-Liver axis Reviewed International journal

    Muto Hisanori, Ito Takanori, Tanaka Taku, Yokoyama Shinya, Yamamoto Kenta, Imai Norihiro, Ishizu Yoji, Maeda Keiko, Honda Takashi, Ishikawa Tetsuya, Kato Asuka, Ohshiro Taichi, Kano Fumiya, Yamamoto Akihito, Sakai Kiyoshi, Hibi Hideharu, Ishigami Masatoshi, Fujishiro Mitsuhiro

    SCIENTIFIC REPORTS   Vol. 11 ( 1 ) page: 18778   2021.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41598-021-98254-8

    Web of Science

    Scopus

    PubMed

  74. Revisiting Prognosis After Liver Transplant in Patients Positive for Hepatitis C Virus: Focus on Hepatitis C Recurrence-Unrelated Complications Reviewed International journal

    Ishigami Masatoshi, Honda Takashi, Ishizu Yoji, Imai Norihiro, Ito Takanori, Yamamoto Kenta, Kamei Hideya, Ogura Yasuhiro, Fujishiro Mitsuhiro

    EXPERIMENTAL AND CLINICAL TRANSPLANTATION   Vol. 19 ( 9 ) page: 935 - 942   2021.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.6002/ect.2021.0197

    Web of Science

    Scopus

    PubMed

  75. Transient deterioration of albumin-bilirubin scores in early post-dose period of molecular targeted therapies in advanced hepatocellular carcinoma with 50% or higher liver occupation A STROBE-compliant retrospective observational study Reviewed International journal

    Muto Hisanori, Kuzuya Teiji, Ito Takanori, Ishizu Yoji, Honda Takashi, Ishikawa Tetsuya, Ishigami Masatoshi, Fujishiro Mitsuhiro

    MEDICINE   Vol. 100 ( 31 ) page: e26820   2021.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/MD.0000000000026820

    Web of Science

    Scopus

    PubMed

  76. Feasibility of patency capsule and colon capsule endoscopy in patients with suspected gastrointestinal stenosis: a prospective study Reviewed International journal

    Otsuka Hiroyuki, Nakamura Masanao, Yamamura Takeshi, Maeda Keiko, Sawade Tsunaki, Mizutani Yasuyuki, Ishikawa Eri, Ishikawa Takuya, Kakushima Naomi, Furukawa Kazuhiro, Ohno Eizaburo, Kawashima Iliroki, Honda Takashi, Ishigami Masatoshi, Fujishiro Mitsuhiro

    NAGOYA JOURNAL OF MEDICAL SCIENCE   Vol. 83 ( 3 ) page: 419 - 430   2021.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.18999/nagjms.83.3.419

    Web of Science

    Scopus

    PubMed

  77. Fecal incontinence and oral regurgitation during duodenal endoscopic submucosal dissection using the water pressure method Reviewed International journal

    Takada Yoshihisa, Hirose Takashi, Nishida Kazuki, Kakushima Naomi, Furukawa Kazuhiro, Furune Satoshi, Ishikawa Eri, Sawada Tsunaki, Maeda Keiko, Yamamura Takeshi, Ishikawa Takuya, Ohno Eizaburo, Nakamura Masanao, Honda Takashi, Ishigami Masatoshi, Kawashima Hiroki, Fujishiro Mitsuhiro

    DIGESTIVE ENDOSCOPY     2021.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/den.14070

    Web of Science

    Scopus

    PubMed

  78. Endoscopic papillectomy for ampullary adenoma and early adenocarcinoma: Analysis of factors related to treatment outcome and long-term prognosis. Reviewed International journal

    Kawashima H, Ohno E, Ishikawa T, Iida T, Tanaka H, Furukawa K, Nakamura M, Honda T, Hashimoto S, Itoh A, Ishigami M, Hirooka Y, Fujishiro M

    Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society   Vol. 33 ( 5 ) page: 858 - 869   2021.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/den.13881

    Web of Science

    Scopus

    PubMed

  79. Lewis score on capsule endoscopy can predict the prognosis in patients with small bowel lesions of Crohn's disease. Reviewed International journal

    Nishikawa T, Nakamura M, Yamamura T, Maeda K, Sawada T, Mizutani Y, Ishikawa E, Ishikawa T, Kakushima N, Furukawa K, Ohno E, Honda T, Kawashima H, Ishigami M, Fujishiro M

    Journal of gastroenterology and hepatology   Vol. 36 ( 7 ) page: 1851 - 1858   2021.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/jgh.15366

    Web of Science

    Scopus

    PubMed

  80. An initial trial of quantitative evaluation of autoimmune pancreatitis using shear wave elastography and shear wave dispersion in transabdominal ultrasound. Reviewed International journal

    Suzuki H, Ishikawa T, Ohno E, Iida T, Uetsuki K, Yashika J, Yamada K, Yoshikawa M, Furukawa K, Nakamura M, Honda T, Ishigami M, Kawashima H, Fujishiro M

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]   Vol. 21 ( 4 ) page: 682 - 687   2021.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.pan.2021.02.014

    Scopus

    PubMed

  81. Immunohistochemical staining for IMP3 in patients with duodenal papilla tumors: assessment of the potential for diagnosing endoscopic resectability and predicting prognosis Reviewed International journal

    Tanaka Hiroyuki, Kawashima Hiroki, Ohno Eizaburo, Ishikawa Takuya, Iida Tadashi, Ishikawa Eri, Furukawa Kazuhiro, Nakamura Masanao, Honda Takashi, Shimoyama Yoshie, Miyahara Ryoji, Kawabe Naoto, Kuzuya Teiji, Hashimoto Senju, Ishigami Masatoshi, Hirooka Yoshiki, Fujishiro Mitsuhiro

    BMC GASTROENTEROLOGY   Vol. 21 ( 1 ) page: 224   2021.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s12876-021-01811-8

    Web of Science

    Scopus

    PubMed

  82. Measurement of fasting breath hydrogen concentration as a simple diagnostic method for pancreatic exocrine insufficiency Reviewed International journal

    Uetsuki Kota, Kawashima Hiroki, Ohno Eizaburo, Ishikawa Takuya, Iida Tadashi, Yamamoto Kenta, Furukawa Kazuhiro, Nakamura Masanao, Honda Takashi, Ishigami Masatoshi, Hirooka Yoshiki, Fujishiro Mitsuhiro

    BMC GASTROENTEROLOGY   Vol. 21 ( 1 ) page: 211   2021.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s12876-021-01776-8

    Web of Science

    Scopus

    PubMed

  83. Tolerability of Molecular-targeted Agents for Hepatocellular Carcinoma Treatment in Haemophiliacs Reviewed International journal

    Yamamoto Takafumi, Imai Norihiro, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Honda Takashi, Okamoto Shuichi, Kanematsu Takeshi, Suzuki Nobuaki, Matsushita Tadashi, Ishigami Masatoshi, Fujishiro Mitsuhiro

    ANTICANCER RESEARCH   Vol. 41 ( 5 ) page: 2569 - 2573   2021.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.21873/anticanres.15035

    Web of Science

    Scopus

    PubMed

  84. Variability measurements provide additional value to shear wave elastography in the diagnosis of pancreatic cancer Reviewed International journal

    Yoshikawa Masakatsu, Ishikawa Takuya, Ohno Eizaburo, Iida Tadashi, Furukawa Kazuhiro, Nakamura Masanao, Honda Takashi, Ishigami Masatoshi, Kinoshita Fumie, Kawashima Hiroki, Fujishiro Mitsuhiro

    SCIENTIFIC REPORTS   Vol. 11 ( 1 ) page: 7409   2021.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41598-021-86979-5

    Web of Science

    Scopus

    PubMed

  85. Filtrated Adipose Tissue-Derived Mesenchymal Stem Cell Lysate Ameliorates Experimental Acute Colitis in Mice. Reviewed International journal

    Nishikawa T, Maeda K, Nakamura M, Yamamura T, Sawada T, Mizutani Y, Ito T, Ishikawa T, Furukawa K, Ohno E, Miyahara R, Kawashima H, Honda T, Ishigami M, Yamamoto T, Matsumoto S, Hotta Y, Fujishiro M

    Digestive diseases and sciences   Vol. 66 ( 4 ) page: 1034 - 1044   2021.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s10620-020-06359-3

    Web of Science

    Scopus

    PubMed

  86. Impact of visceral fat accumulation on the prognosis of patients with cirrhosis Reviewed International journal

    Ishizu Yoji, Ishigami Masatoshi, Honda Takashi, Imai Norihiro, Ito Takanori, Yamamoto Kenta, Fujishiro Mitsuhiro

    CLINICAL NUTRITION ESPEN   Vol. 42   page: 354 - 360   2021.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.clnesp.2021.01.008

    Web of Science

    Scopus

    PubMed

  87. Quality of Life in patients with nonalcoholic fatty liver disease: Structure and related factors focusing on illness uncertainty Reviewed International journal

    Ozawa Naoki, Sato Kazuki, Sugimura Ayumi, Maki Shigeyoshi, Tanaka Taku, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Ishigami Masatoshi, Fujishiro Mitsuhiro, Ishikawa Tetsuya, Ando Shoko

    JAPAN JOURNAL OF NURSING SCIENCE   Vol. 18 ( 3 ) page: e12415   2021.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/jjns.12415

    Web of Science

    Scopus

    PubMed

  88. Simplification of balloon-occluded retrograde transcatheter obliteration procedure using a coaxial double balloon catheter compared with a single-balloon catheter. Reviewed International journal

    Ishizu Y, Ishigami M, Honda T, Kuzuya T, Ito T, Komada T, Fujishiro M

    Japanese journal of radiology   Vol. 39 ( 3 ) page: 296 - 302   2021.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s11604-020-01060-x

    Web of Science

    Scopus

    PubMed

  89. Endoscopic ultrasound elastography for small solid pancreatic lesions with or without main pancreatic duct dilatation. Reviewed International journal

    Kataoka K, Ishikawa T, Ohno E, Iida T, Suzuki H, Uetsuki K, Furukawa K, Nakamura M, Honda T, Ishigami M, Kawashima H, Hirooka Y, Fujishiro M

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]   Vol. 21 ( 2 ) page: 451 - 458   2021.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.pan.2020.12.012

    Scopus

    PubMed

  90. Utility of multiphase contrast enhancement patterns on CEH-EUS for the differential diagnosis of IPMN-derived and conventional pancreatic cancer. Reviewed International journal

    Yashika J, Ohno E, Ishikawa T, Iida T, Suzuki H, Uetsuki K, Yamada K, Yoshikawa M, Gibo N, Shimoyama Y, Ishikawa E, Furukawa K, Nakamura M, Honda T, Ishigami M, Hirooka Y, Kawashima H, Fujishiro M

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]   Vol. 21 ( 2 ) page: 390 - 396   2021.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.pan.2020.12.022

    Scopus

    PubMed

  91. Progression After Molecular Targeted Agents: Hepatic Arterial Changes and Transarterial Chemoembolization in Hepatocellular Carcinoma. Reviewed International journal

    Matsuda N, Imai N, Kuzuya T, Yamamoto K, Ito T, Ishizu Y, Honda T, Ishigami M, Fujishiro M

    In vivo (Athens, Greece)   Vol. 35 ( 2 ) page: 1185 - 1189   2021.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.21873/invivo.12367

    Scopus

    PubMed

  92. Diagnostic yield of colon capsule endoscopy for Crohn's disease lesions in the whole gastrointestinal tract Reviewed International journal

    Yamada Keisaku, Nakamura Masanao, Yamamura Takeshi, Maeda Keiko, Sawada Tsunaki, Mizutani Yasuyuki, Ishikawa Eri, Ishikawa Takuya, Kakushima Naomi, Furukawa Kazuhiro, Ohno Eizaburo, Kawashima Hiroki, Honda Takashi, Ishigami Masatoshi, Fujishiro Mitsuhiro

    BMC GASTROENTEROLOGY   Vol. 21 ( 1 ) page: 75   2021.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s12876-021-01657-0

    Web of Science

    Scopus

    PubMed

  93. 進行肝細胞癌に対するレンバチニブPD後のラムシルマブ治療の初期経験 Reviewed International journal

    葛谷 貞二, 石上 雅敏, 杉山 由晃, 吉岡 直輝, 水野 和幸, 武藤 久哲, 横山 晋也, 田中 卓, 山本 健太, 伊藤 隆徳, 石津 洋二, 本多 隆, 石川 哲也, 藤城 光弘

    Pharma Medica   Vol. 39 ( 2 ) page: 72 - 73   2021.2

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:(株)メディカルレビュー社  

  94. Ustekinumab is effective against small bowel lesions in Crohn's disease: two case reports. Reviewed International journal

    Murate K, Nakamura M, Yamamura T, Maeda K, Sawada T, Mizutani Y, Ishikawa E, Kakushima N, Furukawa K, Ohno E, Honda T, Kawashima H, Ishigami M, Fujishiro M

    Clinical journal of gastroenterology   Vol. 14 ( 1 ) page: 129 - 135   2021.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s12328-020-01242-0

    Web of Science

    Scopus

    PubMed

  95. Safety and efficacy of percutaneous radiofrequency ablation for hepatocellular carcinoma patients with haemophilia Reviewed International journal

    Yamamoto Takafumi, Imai Norihiro, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Honda Takashi, Okamoto Shuichi, Kanematsu Takeshi, Suzuki Nobuaki, Matsushita Tadashi, Ishigami Masatoshi, Fujishiro Mitsuhiro

    HAEMOPHILIA   Vol. 27 ( 1 ) page: 100 - 107   2021.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/hae.14220

    Web of Science

    Scopus

    PubMed

  96. Systematic review and meta-analysis of the diagnostic and therapeutic yield of small bowel endoscopy in patients with overt small bowel bleeding. Reviewed International journal

    Uchida G, Nakamura M, Yamamura T, Furukawa K, Kawashima H, Honda T, Ishigami M, Fujishiro M

    Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society   Vol. 33 ( 1 ) page: 66 - 82   2021.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/den.13669

    Web of Science

    Scopus

    PubMed

  97. Clinical Features of Ischemic Enteritis Diagnosed by Double-Balloon Endoscopy. Reviewed International journal

    Nakamura M, Yamamura T, Maeda K, Sawada T, Mizutani Y, Ishikawa E, Kakushima N, Furukawa K, Ishikawa T, Ohno E, Honda T, Kawashima H, Ishigami M, Fujishiro M

    Canadian journal of gastroenterology & hepatology   Vol. 2021   page: 8875564   2021

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1155/2021/8875564

    Scopus

    PubMed

  98. Increased Frequency of Dysfunctional Siglec-7<sup>-</sup>CD57<sup>+</sup>PD-1<sup>+</sup> Natural Killer Cells in Patients With Non-alcoholic Fatty Liver Disease. Reviewed International journal

    Sakamoto Y, Yoshio S, Doi H, Mori T, Matsuda M, Kawai H, Shimagaki T, Yoshikawa S, Aoki Y, Osawa Y, Yoshida Y, Arai T, Itokawa N, Atsukawa M, Ito T, Honda T, Mise Y, Ono Y, Takahashi Y, Saiura A, Taketomi A, Kanto T

    Frontiers in immunology   Vol. 12   page: 603133   2021

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3389/fimmu.2021.603133

    Scopus

    PubMed

  99. SYSTEMATIC REVIEW AND META-ANALYSIS OF THE DIAGNOSTIC AND THERAPEUTIC YIELD OF SMALL BOWEL ENDOSCOPY IN PATIENTS WITH OVERT SMALL BOWEL BLEEDING Reviewed

    UCHIDA Genta, NAKAMURA Masanao, YAMAMURA Takeshi, FURUKAWA Kazuhiro, KAWASHIMA Hiroki, HONDA Takashi, ISHIGAMI Masatoshi, FUJISHIRO Mitsuhiro

    GASTROENTEROLOGICAL ENDOSCOPY   Vol. 63 ( 9 ) page: 1649 - 1665   2021

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Japan Gastroenterological Endoscopy Society  

    <p>Background: Small bowel endoscopy, including small bowel capsule endoscopy (SBCE) and balloon-assisted endoscopy (BAE), is useful for small bowel bleeding (SBB) assessment. However, the specific management strategy for overt SBB is not well established. This meta-analysis aimed to evaluate the pooled diagnostic yields (DYs) and therapeutic yields (TYs) of small bowel endoscopy in overt SBB and to determine the optimal endoscopy timing.</p><p>Methods: A comprehensive literature search was performed of studies examining the DY and/or TY of small bowel endoscopy in overt SBB. Data on the DY, TY, and timing of small bowel endoscopy were extracted, pooled, and analyzed. The pooled DY and TY of small bowel endoscopy for patients with overt SBB were calculated. Meta-regression and subgroup analysis were performed.</p><p>Results: Twenty-two studies were included. The pooled DY was 65.2% and 74.0% for SBCE and BAE, respectively. The pooled TY of SBCE and BAE was 55.9% and 35.8%, respectively. A meta-regression model showed that the timing of endoscopy was significantly associated with the DY of BAE and the TY of SBCE and BAE.</p><p>Conclusions: Small bowel capsule endoscopy and BAE would be useful diagnostic and therapeutic modalities in overt SBB. According to the subgroup analysis, in which the TY seemed to be higher within 2 days after bleeding for SBCE and BAE, the optimal timing of endoscopy would be within 2 days.</p>

    DOI: 10.11280/gee.63.1649

    Scopus

  100. Feasibility and usefulness of endoscopic ultrasonography-guided shear-wave measurement for assessment of autoimmune pancreatitis activity: a prospective exploratory study Reviewed

    OHNO Eizaburo, HONDA Takashi, HIROOKA Yoshiki, KAWASHIMA Hiroki, ISHIKAWA Takuya, TANAKA Hiroyuki, SAKAI Daisuke, ISHIZU Yoji, KUZUYA Teiji, NAKAMURA Masanao

    Choonpa Igaku   Vol. 48 ( 1 ) page: 35 - 44   2021

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:The Japan Society of Ultrasonics in Medicine  

    <p><b>Purpose</b>: To assess the feasibility and the clinical usefulness of a newly developed endoscopic ultrasonography (EUS) shearwave elastography technique (EUS shear-wave measurement: EUS-SWM) in the diagnosis and treatment of autoimmune pancreatitis (AIP). <b>Methods</b>: Tissue elasticity was measured in the pancreas in 160 patients. The success rate of EUS-SWMs, the velocity of the shear wave (Vs, m/s), and the reliability index of the Vs measurement (VsN) were evaluated, and the elasticity (median Vs) was compared between AIP patients (<I>n</I>=14) and normal controls. <b>Results</b>: A total of 3837 EUS-SWMs were performed without adverse events. Overall, 97.6% (3,743/3,837) were successful. The median VsN was 74%. The median Vs values of the pancreas were as follows: 2.22 m/s in the pancreatic head (push position), 2.36 m/s in the head (pull position), 1.99 m/s in the body, and 2.25 m/s in the tail. The median Vs of the AIP group (2.57 m/s) was significantly higher than that of the normal controls (1.89 m/s) (<I>P</I>=0.0185). The mean Vs significantly decreased from 3.32 m/s to 2.46 m/s after steroid therapy (<I>n</I>=6) (<I>P</I>=0.0234). <b>Conclusion</b>: EUS-SWM is feasible and generates credible results. EUS-SWM was a useful method for assessment of the effect of steroid therapy in AIP patients.</p>

    DOI: 10.3179/jjmu.JJMU.K.22

  101. *The microbiome can predict mucosal healing in small intestine in patients with Crohn's disease. Reviewed International journal

    Hattori S, Nakamura M, Yamamura T, Maeda K, Sawada T, Mizutani Y, Yamamoto K, Ishikawa T, Furukawa K, Ohno E, Honda T, Kawashima H, Ishigami M, Hirooka Y, Fujishiro M

      Vol. 55 ( 12 ) page: 1138 - 1149   2020.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s00535-020-01728-1

    Web of Science

    Scopus

    PubMed

  102. Accuracy of carbon dioxide insufflation for endoscopic retrograde cholangiopancreatography using double-balloon endoscopy Reviewed International journal

    Niwa Yoshiki, Nakamura Masanao, Kawashima Hiroki, Yamamura Takeshi, Maeda Keiko, Sawada Tsunaki, Mizutani Yasuyuki, Ishikawa Eri, Ishikawa Takuya, Kakushima Naomi, Furukawa Kazuhiro, Ohno Eizaburo, Honda Takashi, Ishigami Masatoshi, Fujishiro Mitsuhiro

    WORLD JOURNAL OF GASTROENTEROLOGY   Vol. 26 ( 42 ) page: 6669 - 6678   2020.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3748/wjg.v26.i42.6669

    Web of Science

    Scopus

    PubMed

  103. Endoscopic Activity and Serum TNF-alpha Level at Baseline Are Associated With Clinical Response to Ustekinumab in Crohn's Disease Patients Reviewed International journal

    Murate Kentaro, Maeda Keiko, Nakamura Masanao, Sugiyama Daisuke, Wada Hirotaka, Yamamura Takeshi, Sawada Tsunaki, Mizutani Yasuyuki, Ishikawa Takuya, Furukawa Kazuhiro, Ohno Eizaburo, Honda Takashi, Kawashima Hiroki, Miyahara Ryoji, Ishigami Masatoshi, Nishikawa Hiroyoshi, Fujishiro Mitsuhiro

    INFLAMMATORY BOWEL DISEASES   Vol. 26 ( 11 ) page: 1669 - 1681   2020.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1093/ibd/izaa086

    Web of Science

    Scopus

    PubMed

  104. The albumin-bilirubin score as a predictor of outcomes in Japanese patients with PBC: an analysis using time-dependent ROC Reviewed International journal

    Ito Takanori, Ishigami Masatoshi, Morooka Hikaru, Yamamoto Kenta, Imai Norihiro, Ishizu Yoji, Honda Takashi, Nishimura Daisaku, Tada Toshifumi, Yasuda Satoshi, Toyoda Hidenori, Kumada Takashi, Fujishiro Mitsuhiro

    SCIENTIFIC REPORTS   Vol. 10 ( 1 ) page: 17812   2020.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41598-020-74732-3

    Web of Science

    Scopus

    PubMed

  105. Revisiting the indications for liver transplantation in cirrhotic patients considering the long-term outcomes of cirrhotic patients. Reviewed International journal

    Ishigami M, Honda T, Kuzuya T, Ishizu Y, Ito T, Kamei H, Ogura Y, Fujishiro M

    Journal of hepato-biliary-pancreatic sciences   Vol. 27 ( 9 ) page: 655 - 662   2020.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/jhbp.777

    Web of Science

    Scopus

    PubMed

  106. Limitation of non-transplant treatment and proper timing for liver transplantation in patients with hepatocellular carcinoma considering long-term survival. Reviewed International journal

    Nomura A, Ishigami M, Honda T, Kuzuya T, Ishizu Y, Ito T, Kamei H, Onishi Y, Ogura Y, Fujishiro M

    Medicine   Vol. 99 ( 28 ) page: e21161   2020.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/MD.0000000000021161

    Web of Science

    Scopus

    PubMed

  107. Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignancies Reviewed International journal

    Mizuno Kazuyuki, Ito Takanori, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Kawashima Hiroki, Inukai Yosuke, Toyoda Hidenori, Yokota Kenji, Hase Tetsunari, Maeda Osamu, Kiyoi Hitoshi, Nagino Masato, Hibi Hideharu, Kodera Yasuhiro, Fujimoto Yasushi, Sone Michihiko, Gotoh Momokazu, Ando Yuichi, Akiyama Masashi, Hasegawa Yoshinori, Fujishiro Mitsuhiro

    JOURNAL OF GASTROENTEROLOGY   Vol. 55 ( 6 ) page: 653 - 661   2020.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s00535-020-01677-9

    Web of Science

    Scopus

    PubMed

  108. Complete response of advanced hepatocellular carcinoma achieved by sorafenib dose re-escalation after failure of long-term low-dose-sorafenib treatment combined with transcatheter arterial chemoembolization: a case report. Reviewed International journal

    Muto H, Kuzuya T, Ito T, Ishizu Y, Honda T, Ishikawa T, Ishigami M, Fujishiro M

    Clinical journal of gastroenterology   Vol. 13 ( 3 ) page: 397 - 402   2020.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s12328-019-01066-7

    Web of Science

    Scopus

    PubMed

  109. Correlation of serum zinc levels with pathological and laboratory findings in patients with nonalcoholic fatty liver disease Reviewed International journal

    Ito Takanori, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Ishikawa Tetsuya, Toyoda Hidenori, Kumada Takashi, Fujishiro Mitsuhiro

    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY   Vol. 32 ( 6 ) page: 748 - 753   2020.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/MEG.0000000000001587

    Web of Science

    Scopus

    PubMed

  110. Nonexposed wall-inversion surgery as a novel local resection method for neoplasms in the gastrointestinal tract. Reviewed International journal

    Fujishiro M, Furukawa K, Yamamura T, Nakamura M, Honda T, Maeda O, Ishigami M, Kawashima H

    Nagoya journal of medical science   Vol. 82 ( 2 ) page: 175 - 182   2020.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.18999/nagjms.82.2.175

    Web of Science

    Scopus

    PubMed

  111. Sorafenib <i>vs</i>. Lenvatinib as First-line Therapy for Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis. Reviewed International journal

    Kuzuya T, Ishigami M, Ito T, Ishizu Y, Honda T, Ishikawa T, Fujishiro M

    Anticancer research   Vol. 40 ( 4 ) page: 2283 - 2290   2020.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.21873/anticanres.14193

    Web of Science

    Scopus

    PubMed

  112. Initial Experience of Ramucirumab Treatment After Lenvatinib Failure for Patients With Advanced Hepatocellular Carcinoma. Reviewed International journal

    Kuzuya T, Ishigami M, Ito T, Ishizu Y, Honda T, Ishikawa T, Fujishiro M

    Anticancer research   Vol. 40 ( 4 ) page: 2089 - 2093   2020.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.21873/anticanres.14167

    Web of Science

    Scopus

    PubMed

  113. Favorable radiological antitumor response at 2 weeks after starting lenvatinib for patients with advanced hepatocellular carcinoma Reviewed International journal

    Kuzuya Teiji, Ishigami Masatoshi, Ito Takanori, Ishizu Yoji, Honda Takashi, Ishikawa Tetsuya, Fujishiro Mitsuhiro

    HEPATOLOGY RESEARCH   Vol. 50 ( 3 ) page: 374 - 381   2020.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/hepr.13452

    Web of Science

    Scopus

    PubMed

  114. *Microbiota profile is different for early and invasive colorectal cancer and is consistent throughout the colon. Reviewed International coauthorship International journal

    Zorron Cheng Tao Pu L, Yamamoto K, Honda T, Nakamura M, Yamamura T, Hattori S, Burt AD, Singh R, Hirooka Y, Fujishiro M

    Journal of gastroenterology and hepatology   Vol. 35 ( 3 ) page: 433 - 437   2020.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/jgh.14868

    Web of Science

    Scopus

    PubMed

  115. Relationship Between Adverse Events and Microbiomes in Advanced Hepatocellular Carcinoma Patients Treated With Sorafenib. Reviewed International journal

    Yamamoto K, Kuzuya T, Honda T*, Ito T, Ishizu Y, Nakamura M, Miyahara R, Kawashima H, Ishigami M, Fujishiro M

    Anticancer research   Vol. 40 ( 2 ) page: 665 - 676   2020.2

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.21873/anticanres.13996

    Web of Science

    Scopus

    PubMed

  116. Effect of weight change and lifestyle modifications on the development or remission of nonalcoholic fatty liver disease: sex-specific analysis. Reviewed International journal

    Yoshioka N, Ishigami M, Watanabe Y, Sumi H, Doisaki M, Yamaguchi T, Ito T, Ishizu Y, Kuzuya T, Honda T, Ishikawa T, Haruta JI, Fujishiro M

    Scientific reports   Vol. 10 ( 1 ) page: 481   2020.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41598-019-57369-9

    Web of Science

    Scopus

    PubMed

  117. Development of a novel anti-hepatitis B virus agent via Sp1 Reviewed International journal

    Hayakawa Michiyo, Umeyama Hideaki, Iwadate Mitsuo, Taguchi Y. -H., Yano Yoshihiko, Honda Takashi, Itami-Matsumoto Saori, Kozuka Ritsuzo, Enomoto Masaru, Tamori Akihiro, Kawada Norifumi, Murakami Yoshiki

    SCIENTIFIC REPORTS   Vol. 10 ( 1 ) page: 47   2020.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41598-019-56842-9

    Web of Science

    Scopus

    PubMed

  118. Rapid increase of platelet counts during antiviral therapy in patients with hepatitis C virus infection Reviewed International journal

    Ishizu Yoji, Ishigami Masatoshi, Hayashi Kazuhiko, Honda Takashi, Kuzuya Teiji, Ito Takanori, Fujishiro Mitsuhiro

    HEPATOLOGY RESEARCH   Vol. 50 ( 1 ) page: 47 - 56   2020.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/hepr.13426

    Web of Science

    Scopus

    PubMed

  119. Serum Nutritional Markers as Prognostic Factors for Hepatic and Extrahepatic Carcinogenesis in Japanese Patients with Nonalcoholic Fatty Liver Disease. Reviewed International journal

    Ito T, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Ishikawa T, Toyoda H, Kumada T, Fujishiro M

    Nutrition and cancer   Vol. 72 ( 5 ) page: 884 - 891   2020

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1080/01635581.2019.1653474

    Web of Science

    Scopus

    PubMed

  120. Refractory Ulcerative Colitis Improved by Scheduled Combination Therapy of Vedolizumab and Granulocyte and Monocyte Adsorptive Apheresis Reviewed International journal

    Nakamura Masanao, Yamamura Takeshi, Maeda Keiko, Sawada Tsunaki, Mizutani Yasuyuki, Ishikawa Eri, Ohashi Ayako, Kajikawa Go, Furukawa Kazuhiro, Ohno Eizaburo, Honda Takashi, Kawashima Hiroki, Ishigami Masatoshi, Fujishiro Mitsuhiro

    INTERNAL MEDICINE   Vol. 59 ( 23 ) page: 3009 - 3014   2020

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.2169/internalmedicine.5302-20

    Web of Science

    Scopus

    PubMed

  121. Efficacy and Safety of Sorafenib in Unresectable Hepatocellular Carcinoma with Bile Duct Invasion. Reviewed International journal

    Tanaka T, Kuzuya T, Ishigami M, Ito T, Ishizu Y, Honda T, Ishikawa T, Fujishiro M

    Oncology   Vol. 98 ( 9 ) page: 621 - 629   2020

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1159/000507051

    Web of Science

    Scopus

    PubMed

  122. A Prospective Study of Factors Associated with Abdominal Pain in Patients during Unsedated Colonoscopy Using a Magnifying Endoscope. Reviewed International journal

    Suzuki H, Nakamura M, Yamamura T, Maeda K, Sawada T, Mizutani Y, Ishikawa T, Furukawa K, Ohno E, Honda T, Kawashima H, Ishigami M, Fujishiro M

    Internal medicine (Tokyo, Japan)   Vol. 59 ( 15 ) page: 1795 - 1801   2020

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.2169/internalmedicine.4267-19

    PubMed

  123. Sarcopenia impairs health-related quality of life in cirrhotic patients. Reviewed International journal

    Ando Y, Ishigami M, Ito T, Ishizu Y, Kuzuya T, Honda T, Ishikawa T, Fujishiro M

    European journal of gastroenterology & hepatology   Vol. 31 ( 12 ) page: 1550 - 1556   2019.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/MEG.0000000000001472

    Web of Science

    Scopus

    PubMed

  124. Spleen stiffness by 2-D shear wave elastography is the most accurate predictor of high-risk esophagogastric varices in children with biliary atresia Reviewed International journal

    Yokoyama Shinya, Ishigami Masatoshi, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Ito Takanori, Hirooka Yoshiki, Tanaka Yujiro, Tainaka Takahisa, Shirota Chiyoe, Chiba Kosuke, Uchida Hiroo, Fujishiro Mitsuhiro

    HEPATOLOGY RESEARCH   Vol. 49 ( 10 ) page: 1162 - 1168   2019.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/hepr.13381

    Web of Science

    Scopus

    PubMed

  125. Feasibility and usefulness of endoscopic ultrasonography-guided shear-wave measurement for assessment of autoimmune pancreatitis activity: a prospective exploratory study. Reviewed International journal

    Ohno E, Hirooka Y, Kawashima H, Ishikawa T, Tanaka H, Sakai D, Ishizu Y, Kuzuya T, Nakamura M, Honda T

    Journal of medical ultrasonics (2001)   Vol. 46 ( 4 ) page: 425 - 433   2019.10

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s10396-019-00944-4

    Web of Science

    Scopus

    PubMed

  126. Antifibrotic Effects of 1,25(OH)2D3 on Nonalcoholic Steatohepatitis in Female Mice. Reviewed International journal

    Ma L, Ishigami M, Honda T, Yokoyama S, Yamamoto K, Ishizu Y, Kuzuya T, Hayashi K, Hirooka Y, Goto H.

    Digestive diseases and sciences   Vol. 64 ( 9 ) page: 2581 - 2590   2019.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s10620-019-05560-3

    Scopus

    PubMed

  127. Clinical characteristics and outcomes of candidates for second-line therapy, including regorafenib and ramucirumab, for advanced hepatocellular carcinoma after sorafenib treatment. Reviewed International journal

    Kuzuya T, Ishigami M, Ito T, Ishizu Y, Honda T, Ishikawa T, Hirooka Y, Fujishiro M

    Hepatology research : the official journal of the Japan Society of Hepatology   Vol. 49 ( 9 ) page: 1054 - 1065   2019.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/hepr.13358

    Web of Science

    Scopus

    PubMed

  128. Complete response by vitamin K2 analog monotherapy in sorafenib-failure advanced hepatocellular carcinoma: A case report. Reviewed International journal

    Kuzuya T, Ishigami M, Ishizu Y, Honda T, Hayashi K, Ishikawa T, Hirooka Y, Goto H.

    Hepatol Res.   Vol. 49 ( 3 ) page: 360-364   2019.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  129. Successful treatment of esophageal bleeding due to rupture of major aortopulmonary collateral arteries by transcatheter arterial embolization. Reviewed International journal

    Ito T, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Matsushima M, Kato T, Hirooka Y

    Clinical journal of gastroenterology   Vol. 12 ( 1 ) page: 20 - 24   2019.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s12328-018-0895-8

    Web of Science

    Scopus

    PubMed

  130. Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients. Reviewed International journal

    Ito T, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Nishimura D, Toyoda H, Kumada T, Goto H, Hirooka Y

    Journal of gastroenterology and hepatology   Vol. 34 ( 1 ) page: 207 - 214   2019.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/jgh.14448

    Scopus

    PubMed

  131. The Prevalence of Mixed Hepatitis C Virus Genotype Infection and Its Effect on the Response to Direct-Acting Antivirals Therapy. Reviewed International journal

    Hayashi K, Tachi K, Shimizu Y, Nagano K, Ishizu Y, Kuzuya T, Honda T, Ishigami M, Hirooka Y, Hattori M, Goto H

    Intervirology   Vol. 62 ( 1 ) page: 23 - 29   2019

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1159/000499691

    Web of Science

    Scopus

    PubMed

  132. Successful Treatment of Hepatocellular Carcinoma with Regorafenib after Sorafenib-induced Hypersensitivity Reviewed International journal

    Yoshioka Naoki, Kuzuya Teiji, Ito Takanori, Ishizu Yoji, Honda Takashi, Ishikawa Tetsuya, Ishigami Masatoshi, Fujishiro Mitsuhiro

    INTERNAL MEDICINE   Vol. 58 ( 19 ) page: 2803 - 2808   2019

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.2169/internalmedicine.2812-19

    Web of Science

    Scopus

    PubMed

  133. Late relapse of hepatitis C virus in patients with sustained virological response after daclatasvir and asunaprevir therapy. Reviewed International journal

    Hayashi K, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hirooka Y, Toyoda H, Kumada T, Hattori M, Katano Y, Goto H.

    J Viral Hepat.   Vol. 25 ( 12 ) page: 1446 - 1451   2018.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  134. Utility of contrast-enhanced ultrasonography with perflubutane in evaluating indications for diagnostic percutaneous tumor biopsy in a case of hepatic sclerosed hemangioma. Reviewed International journal

    Ando Y, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hirooka Y

    Clinical journal of gastroenterology   Vol. 11 ( 6 ) page: 514 - 520   2018.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s12328-018-0880-2

    Web of Science

    Scopus

    PubMed

  135. Substitutions in interferon sensitivity-determining region and hepatocarcinogenesis after hepatitis C virus eradication. Reviewed International journal

    Yasuda S, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Toyoda H, Kumada T, Hirooka Y, Goto H.

    J Gastroenterol Hepatol   Vol. 33 ( 11 ) page: 1904-1911   2018.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  136. Skeletal muscle fat deposition is associated with hepatocellular carcinoma development in patients with chronic liver disease. Reviewed International journal

    Tachi Y, Kozuka A, Hirai T, Kojima Y, Ishizu Y, Honda T, Kuzuya T, Hayashi K, Ishigami M, Goto H.

    Nutrition   Vol. 54   page: 83-88   2018.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  137. Predictive ability of shear wave elastography for pruritus in chronic hepatitis C patients with sustained virological response. Reviewed International journal

    Tachi Y, Hirai T, Kojima Y, Ishizu Y, Honda T, Kuzuya T, Hayashi K, Ishigami M, Goto H, Katano Y.

    Eur J Gastroenterol Hepatol.   Vol. 30 ( 9 ) page: 1066-1072   2018.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  138. Daclatasvir and asunaprevir treatment in patients infected by genotype 1b of hepatitis C virus with no or subtle resistant associated substitutions (RAS) in NS5A-Y93 Reviewed International journal

    Ishigami Masatoshi, Hayashi Kazuhiko, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Ishikawa Tetsuya, Nakano Isao, Urano Fumihiro, Kumada Takashi, Yoshioka Kentaro, Hirooka Yoshiki, Goto Hidemi

    JOURNAL OF MEDICAL VIROLOGY   Vol. 90 ( 4 ) page: 736 - 744   2018.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/jmv.24978

    Web of Science

    PubMed

  139. Impact of myosteatosis on skeletal muscle volume loss in patients with chronic liver disease. Reviewed International journal

    Tachi Y, Kozuka A, Hirai T, Ishizu Y, Honda T, Kuzuya T, Hayashi K, Ishigami M, Goto H.

    J Gastroenterol Hepatol     2018.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/jgh.14133

    PubMed

  140. Occurrence of late relapse of hepatitis C virus confirmed by molecular analysis after sustained virologic response to interferon-ribavirin-based therapy Reviewed International journal

    Hayashi Kazuhiko, Ishigami Masatoshi, Yasuda Satoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Ishikawa Tetsuya, Hirooka Yoshiki, Goto Hidemi

    HEPATOLOGY RESEARCH   Vol. 48 ( 3 ) page: E78 - E86   2018.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/hepr.12929

    Web of Science

    PubMed

  141. Prognostic Factors Associated with Postprogression Survival in Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib Not Eligible for Second-Line Regorafenib Treatment. Reviewed International journal

    Kuzuya T, Ishigami M, Ishizu Y, Honda T, Hayashi K, Ishikawa T, Nakano I, Hirooka Y, Goto H

    Oncology   Vol. 95 ( 2 ) page: 91 - 99   2018

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1159/000488453

    PubMed

  142. Liver stiffness measurement predicts hepatocellular carcinoma development in patients treated with direct-acting antivirals. Reviewed International journal

    Tachi Y, Hirai T, Kojima Y, Ishizu Y, Honda T, Kuzuya T, Hayashi K, Ishigami M, Goto H

    JGH open : an open access journal of gastroenterology and hepatology   Vol. 1 ( 1 ) page: 44 - 49   2017.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/jgh3.12007

    Web of Science

    PubMed

  143. Utility of Doppler ultrasonography for diagnosing and assessing treatment effects in liver compartment syndrome Reviewed International journal

    Ando Yusuke, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Hayashi Kazuhiko, Ishikawa Tetsuya, Goto Hidemi, Hirooka Yoshiki

    CLINICAL JOURNAL OF GASTROENTEROLOGY   Vol. 10 ( 3 ) page: 265 - 269   2017.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s12328-017-0741-4

    Web of Science

    PubMed

  144. Real World Data of Daclatasvir and Asunaprevir Combination Therapy for HCV Genotype 1b Infection in Patients With Renal Dysfunction Reviewed International journal

    Ishigami Masatoshi, Hayashi Kazuhiko, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Ishikawa Tetsuya, Nakano Isao, Urano Fumihiro, Kumada Takashi, Yoshioka Kentaro, Goto Hidemi, Hirooka Yoshiki

    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY   Vol. 15 ( 5 ) page: 787 - 788   2017.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.cgh.2016.12.009

    Web of Science

    PubMed

  145. Liver fibrosis indices for identifying patients at low risk of developing hepatocellular carcinoma after eradication of HCV. Reviewed International journal

    Toyoda H, Tada T, Tachi Y, Hirai T, Yasuda S, Honda T, Hayashi K, Ishigami M, Goto H, Kumada T.

    Antivir Ther.   Vol. 22 ( 3 ) page: 185 - 193   2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3851/IMP3081

    Web of Science

    PubMed

  146. Daclatasvir and asunaprevir treatment in patients with severe liver fibrosis by HCV genotype 1b infection: Real world data. Reviewed International journal

    Ishigami M, Hayashi K, Honda T, Kuzuya T, Ishizu Y, Ishikawa T, Nakano I, Urano F, Kumada T, Yoshioka K, Goto H, Hirooka Y.

    J Gastroenterol Hepatol   Vol. 32 ( 11 ) page: 1879-1886   2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  147. Low skeletal muscle mass predicts early mortality in cirrhotic patients with acute variceal bleeding. Reviewed International journal

    Ishizu Y, Ishigami M, Kuzuya T, Honda T, Hayashi K, Ishikawa T, Hirooka Y, Goto H.

    Nutrition.   Vol. 42   page: 87-91   2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  148. Cumulative incidence and risk factors for the development of hepatocellular carcinoma in patients with chronic hepatitis B who achieved sustained disappearance of viremia by nucleos(t)ide analog treatment. Reviewed International journal

    Ando Y, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Ishikawa T, Nakano I, Hirooka Y, Goto H.

    Hepatol Res     2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/hepr.12976.

  149. Occurrence of late relapse of hepatitis C virus confirmed by molecular analysis after sustained virologic response to interferon-ribavirin-based therapy. Reviewed International journal

    Hayashi K, Ishigami M, Yasuda S, Ishizu Y, Kuzuya T, Honda T, Ishikawa T, Hirooka Y, Goto H.

    Hepatol Res     2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/hepr.12929.

  150. Liver stiffness reduction correlates with histological characteristics of Hepatitis C patients with sustained virological response Reviewed International journal

    Tachi Y, Hirai T, Kojima Y, Ishizu Y, Honda T, Kuzuya T, Hayashi K, Ishigami M, Goto H.

    Liver Int.   Vol. 38 ( 1 ) page: 59 - 67   2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/liv.13486.

  151. A comparison of direct sequencing and Invader assay for Y93H mutation and response to interferon-free therapy in hepatitis C virus genotype 1b Reviewed International journal

    Hayashi K, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Kawashima H, Ishikawa T, Tachi Y, Hattori M, Katano Y, Goto H, Hirooka Y.

    J Gastroenterol Hepatol     2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/jgh.13809.

  152. Hepatocyte-Specific Depletion of Ubiquitin Regulatory X Domain Containing Protein 8 Accelerates Fibrosis in a Mouse Non-Alcoholic Steatohepatitis Model Reviewed International journal

    Imai N, Suzuki M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Ishigami M, Hirooka Y, Ishikawa T, Goto H, Fujimoto T.

    Histochemistry and Cell Biology   Vol. 183 ( 3 ) page: 219-227   2017

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  153. Clinical characteristics and molecular analysis of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients during or after immunosuppressive or cytotoxic chemotherapy Reviewed International journal

    Hayashi Kazuhiko, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Tachi Yoshihiko, Ishikawa Tetsuya, Katano Yoshiaki, Yoshioka Kentaro, Toyoda Hidenori, Kumada Takashi, Goto Hidemi, Hirooka Yoshiki

    JOURNAL OF GASTROENTEROLOGY   Vol. 51 ( 11 ) page: 1081 - 1089   2016.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s00535-016-1187-z

    Web of Science

    PubMed

  154. Fever within 2 Weeks of Sorafenib Therapy Predicts Favorable Treatment Efficacy in Patients with Advanced Hepatocellular Carcinoma. Reviewed International journal

    Kuzuya T, Ishigami M, Ishizu Y, Honda T, Hayashi K, Ishikawa T, Nakano I, Goto H, Hirooka Y.

    Oncology.   Vol. 91 ( 5 ) page: 261-266   2016.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  155. A case of acute hepatitis B in a chronic hepatitis C patient after daclatasvir and asunaprevir combination therapy: hepatitis B virus reactivation or acute self-limited hepatitis? Reviewed International journal

    Hayashi Kazuhiko, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Nishimura Daisaku, Goto Hidemi, Hirooka Yoshiki

    CLINICAL JOURNAL OF GASTROENTEROLOGY   Vol. 9 ( 4 ) page: 252 - 256   2016.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s12328-016-0657-4

    Web of Science

    PubMed

  156. Liver stiffness measurement using acoustic radiation force impulse elastography in hepatitis C virus-infected patients with a sustained virological response. Reviewed International journal

    Tachi Y, Hirai T, Kojima Y, Miyata A, Ohara K, Ishizu Y, Honda T, Kuzuya T, Hayashi K, Ishigami M, Goto H.

    Alimentary Pharmacology Therapeutics   Vol. 44 ( 4 ) page: 346-55   2016.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  157. Clinical characteristics and molecular analysis of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients during or after immunosuppressive or cytotoxic chemotherapy. Reviewed International journal

    Hayashi K, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Tachi Y, Ishikawa T, Katano Y, Yoshioka K, Toyoda H, Kumada T, Goto H, Hirooka Y.

    J Gastroenterol.   Vol. 51 ( 11 ) page: 1081-1089   2016.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  158. *DSS colitis promotes tumorigenesis and fibrogenesis in a choline-deficient high-fat diet-induced NASH mouse model. Reviewed International journal

    Achiwa K, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Hirooka Y, Katano Y, Goto H.

    Biochem Biophys Res Commun   Vol. 470 ( 1 ) page: 15 - 21   2016.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  159. α-fetoprotein levels after interferon therapy predict regression of liver fibrosis in patients with sustained virological response Reviewed International journal

    Tachi Y, Hirai T, Ishizu Y, Honda T, Kuzuya T, Hayashi K, Ishigami M, Goto H.

    J Gastroenterol Hepatol   Vol. 31 ( 5 ) page: 1001 - 1008   2016

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/jgh.13245.

  160. Real world data of daclatasvir and asunaprevir combination therapy for HCV genotype 1b infection in patients with renal dysfunction Reviewed International journal

    Ishigami M, Hayashi K, Honda T, Kuzuya T, Ishizu Y, Ishikawa T, Nakano I, Urano F, Kumada T, Yoshioka K, Goto H, Hirooka Y.

    Clin Gastroenterol Hepatol.   Vol. 15 ( 5 ) page: 787-788   2016

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  161. Immunoglobulin G4-associated autoimmune hepatitis later complicated by autoimmune pancreatitis: A case report. Reviewed International journal

    Ishizu Y, Ishigami M, Kuzuya T, Honda T, Hayashi K, Nakano I, Hirooka Y, Goto H.

    Hepatol Res   Vol. 46 ( 6 ) page: 601-6   2015.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/hepr.12593.

  162. *Raloxifene Ameliorates Liver Fibrosis of Nonalcoholic Steatohepatitis Induced by Choline-Deficient High-Fat Diet in Ovariectomized Mice. Reviewed International journal

    Luo F, Ishigami M, Achiwa K, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Ishikawa T, Katano Y, Goto H.

    Dig Dis Sci   Vol. 60 ( 9 ) page: 2730-2739   2015.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  163. Early Clinical Response after 2 Weeks of Sorafenib Therapy Predicts Outcomes and Anti-Tumor Response in Patients with Advanced Hepatocellular Carcinoma. Reviewed International journal

    Kuzuya T, Ishigami M, Ishizu Y, Honda T, Hayashi K, Katano Y, Hirooka Y, Ishikawa T, Nakano I, Goto H.

    ProS One.   Vol. 10 ( 9 ) page: e0138776   2015.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1371/journal.pone.0138776

  164. Reactivation of resolved infection with the hepatitis B virus immune escape mutant G145R during dasatinib treatment for chronic myeloid leukemia. Reviewed International journal

    Ando T, Kojima K, Isoda H, Eguchi Y, Honda T, Ishigami M, Kimura S

    International journal of hematology   Vol. 102 ( 3 ) page: 379 - 82   2015.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s12185-015-1788-y

    PubMed

  165. Association between responses to interferon therapy and genetic variation in interferon -28B and the core region of hepatitis C virus gentype 3a Reviewed International journal

    Yamada K, Ishigami M, Kuzuya T, Honda T, Hayashi K, Goto H.

    J Med Virol.   Vol. 87 ( 8 ) page: 1361-1367   2015.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  166. Effect of hyperglycemia on hepatocellular carcinoma development in diabetes. Reviewed International journal

    Niwa Y, Ishikawa K, Ishigami M, Honda T, Achiwa K, Izumoto T, Maekawa R, Hosokawa K, Iida A, Seino Y, Hamada Y, Goto H, Oiso Y, Arima H, Tsunekawa S.

    Biochem Biophys Res Commun   Vol. 463 ( 3 ) page: 344 - 350   2015.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  167. Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus. Reviewed International journal

    Tachi Y, Hirai T, Toyoda H, Tada T, Hayashi K, Honda T, Ishigami M, Goto H, Kumada T.

    ProS One.   Vol. 10 ( 7 ) page: e0133515   2015.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  168. Evaluation of Liver Function in Patients With Liver Cirrhosis-Comparison of Child-Pugh Score and MELD Score Reviewed International journal

    Ishigami Masatoshi, Hayashi Kazuhiko, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Onishi Yasuharu, Kamei Hideya, Ogura Yasuhiro, Goto Hidemi

      Vol. 99   page: 170 - 170   2015.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Web of Science

  169. *Hepatitis B e antigen and hepatitis B surface antigen seroclearance with emergence of lamivudine-associated mutation and core mutation after elevation of CD4 in a patient with hepatitis B and HIV Reviewed International journal

    Honda T, Ishigami M, Luo F, Ishizu Y, Kuzuya T, Hayashi K, Itoh A, Hirooka Y, Ishikawa T, Nakano I, Katano Y, Goto H.

    Internal Medicine   Vol. 54 ( 6 ) page: 585-590   2015.6

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  170. Endoscopic treatment of esophageal varices on hemophilic patients with liver cirrohosis Reviewed International journal

    Ishizu Y, Ishigami M, Kuzuya T, Honda T, Hayashi K, Goto H.

    Gastrointest Endosc   Vol. 81 ( 4 ) page: 1059-1060   2015.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  171. Progressive fibrosis significantly correlates with hepatocellular carcinoma in patients with a sustained virological response. Reviewed International journal

    Tachi Y, Hirai T, Miyata A, Ohara K, Iida T, Ishizu Y, Honda T, Kuzuya T, Hayashi K, Ishigami M, Goto H.

    Hepatol Res.   Vol. 45 ( 2 ) page: 238 - 246   2015.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/hepr.12331.

  172. Association of interleukin 28B polymorphism and mutations in the NS5A region of hepatitis C virus genotype 2 with interferon responsiveness Reviewed International journal

    Hayashi K, Katano Y, Ishuzu Y, Kuzuya T, Honda T, Ishigami M, Itoh A, Hirooka Y, Ishikawa T, Nakano I, Yoshioka K, Toyoda H, Kumada T, Goto H.

    J Gastroenterol Hepatol   Vol. 30 ( 1 ) page: 178-183   2015.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  173. Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques. Reviewed International journal

    Imai N, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Hirooka Y, Goto H

    World journal of hepatology   Vol. 6 ( 12 ) page: 844 - 50   2014.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.4254/wjh.v6.i12.844

    PubMed

  174. Frequent incidence of escape mutants after successful hepatitis B vaccine response and stopping of nucleos(t)ide analogues in liver transplant recipients Reviewed International journal

    Ishigami M, Honda T, Ishizu Y, Onishi Y, Kamei H, Hayashi K, Ogura Y, Hirooka Y, Goto H.

    Liver Transpl.   Vol. 20 ( 10 ) page: 1211-1120   2014.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  175. A pediatric case of hepatitis B virus subgenotype A2 in Japan. Reviewed International journal

    Hayashi K, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Itoh A, Hirooka Y, Ishikawa T, Nakano I, Ito Y, Kimura H, Katano Y, Goto H

    Clinical journal of gastroenterology   Vol. 6 ( 5 ) page: 383 - 5   2013.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s12328-013-0402-1

    PubMed

  176. The relationship between the fever and the disappearance or decrease of lesion contrast on contrast enhanced CT images after 2 weeks of sorafenib treatment for patients with advanced hepatocellular carcinoma Reviewed

    KUZUYA Teiji, ISHIGAMI Masatoshi, NIINOMI Takurou, IMAI Norihiro, ACHIWA Kouichi, ARAKAWA Takahiro, YAMADA Keiichi, NAKANO Satoshi, ISHIZU Yoji, HONDA Takashi, HAYASHI Kazuhiko, ISHIKAWA Tetsuya, NAKANO Isao, KATANO Yoshiaki, ITOH Akihiro, HIROOKA Yoshiki, GOTO Hidemi

    Kanzo   Vol. 54 ( 7 ) page: 505 - 506   2013.7

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:The Japan Society of Hepatology  

    We investigated the relationship between the fever and the disappearance or decrease of lesion contrast on contrast enhanced CT images after 2 weeks of sorafenib treatment for patients with advanced hepatocellular carcinoma (HCC). Subjects were 64 patients who began sorafenib therapy. Contrast enhanced CT images were taken at baseline and after 2 weeks of sorafenib treatment. In patients with fever, the ratio of patients demonstrating the disappearance or decrease of lesion contrast on contrast enhanced CT images was significantly higher than in those without fever (91.3% and 61.0%, respectively, p=0.010, Fisher's exact probability test). The results suggested the relationship between the fever and contrast change on contrast enhanced CT.<br>

    DOI: 10.2957/kanzo.54.505

  177. An increase in lesion density can predict lower local recurrence after transarterial chemoembolization in patients with hepatocellular carcinoma. Reviewed International journal

    Imai N, Katano Y, Kuzuya T, Honda T, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Goto H.

    Hepatogastroenterology   Vol. 60 ( 125 ) page: 965 - 970   2013.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  178. Pegylated interferon monotherapy in patients with chronic hepatitis C with low viremia and its relationship to mutations in the NS5A region and the single nucleotide polymorphism of interleukin-28B. Reviewed International journal

    Hayashi K, Katano Y, Masuda H, Ishizu Y, Kuzuya T, Honda T, Ishigami M, Itoh A, Hirooka Y, Nakano I, Ishikawa T, Urano F, Yoshioka K, Toyoda H, Kumada T, Goto H.

    Hepatol Res   Vol. 43 ( 6 ) page: 580-588   2013

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  179. Clinical trial of percutaneous radio frequency ablation therapy by two-step insertion method using VirtuTRAX<sup>TM</sup> instrument navigator Reviewed

    Kuzuya Teiji, Hayashi Kazuhiko, Ishigami Masatoshi, Ishikawa Tetsuya, Nakano Isao, Katano Yoshiaki, Itoh Akihiro, Hirooka Yoshiki, Izumi Namiki, Goto Hidemi, Ishizu Yoji, Niinomi Takurou, Imai Norihiro, Achiwa Kouichi, Arakawa Takahiro, Yamada Keiichi, Nakano Satoshi, Honda Takashi

    Kanzo   Vol. 54 ( 12 ) page: 850 - 853   2013

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:The Japan Society of Hepatology  

    We performed percutaneous radio frequency ablation (RFA) therapy by two-step insertion method using VirtuTRAX<sup>TM</sup> (GE Healthcare, USA) instrument navigator. Subjects were 16 patients (23 nodules) with hepatocellular carcinoma. VirtuTRAX<sup>TM</sup> position sensor was attached to the hilt of 14-gauge outer needle. In all cases, we could perform 17- gauge Cool-tip RFA without the positional gap between the virtual tract and the actual needle which was caused by the deflection of the needle. The reasons without causing the positional gap were that the outer needle was more rigid than Cool-tip needle, and that it was inserted using initial insertion of a 21-gauge guided needle. RFA by two-step insertion method using VirtuTRAX<sup>TM</sup> is suggested to be more safe and effective than conventional RFA.

    DOI: 10.2957/kanzo.54.850

  180. Role of naofen in apoptosis of hepatocytes induced by lipopolysaccharide through mitochondrial signaling in rats Reviewed International journal

    Fan JH, Feng GG, Huang L, Tsunekawa K, Honda T, Katano Y, Hirooka Y, Goto H, Kandatsu N, Ando K, Fujiwara Y, Koide T, Okada S, Ishikawa N.

    Hepatol Res   Vol. 42 ( 7 ) page: 696-705   2012.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  181. Clinical impact of HFE mutations in Japanese patients with chronic hepatitis C Reviewed International journal

    Ishizu Yoji, Katano Yoshiaki, Honda Takashi, Hayashi Kazuhiko, Ishigami Masatoshi, Itoh Akihiro, Hirooka Yoshiki, Nakano Isao, Goto Hidemi

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   Vol. 27 ( 6 ) page: 1112 - 1116   2012.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/j.1440-1746.2011.06976.x

    Web of Science

    PubMed

  182. Prevalence of hepatitis C virus genotype 1a in Japan and correlation of mutations in the NS5A region and single-nucleotide polymorphism of interleukin-28B with the response to combination therapy with pegylated-interferon-alpha 2b and ribavirin. Reviewed International journal

    Hayashi K, Katano Y, Kuzuya T, Tachi Y, Honda T, Ishigami M, Itoh A, Hirooka Y, Ishikawa T, Nakano I, Urano F, Yoshioka K, Toyoda H, Kumada T, Goto H.

    J Med Virol.   Vol. 84 ( 3 ) page: 438-444   2012.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  183. Predictive value of early viral dynamics during peginterferon and ribavirin combination therapy based on genetic polymorphisms near the IL28B gene in patients infected with HCV genotype 1b. Reviewed International journal

    Toyoda H, Kumada T, Tada T, Hayashi K, Honda T, Katano Y, Goto H, Kawaguchi T, Murakami Y, Matsuda F.

    J Med Virol.   Vol. 84 ( 1 ) page: 61-70   2012.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  184. Association of interleukin 28B and mutations in the core and NS5A region of hepatitis C virus with response to peg-interferon and ribavirin therapy Reviewed International journal

    Hayashi Kazuhiko, Katano Yoshiaki, Honda Takashi, Ishigami Masatoshi, Itoh Akihiro, Hirooka Yoshiki, Ishikawa Tetsuya, Nakano Isao, Yoshioka Kentaro, Toyoda Hidenori, Kumada Takashi, Goto Hidemi

    LIVER INTERNATIONAL   Vol. 31 ( 9 ) page: 1359 - 1365   2011.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/j.1478-3231.2011.02571.x

    Web of Science

    PubMed

  185. Antiviral combination therapy with peginterferon and ribavirin does not induce a therapeutically resistant mutation in the HCV core region regardless of genetic polymorphism near the IL28B gene. Reviewed International journal

    Toyoda H, Kumada T, Hayashi K, Honda T, Katano Y, Goto H, Kawaguchi T, Murakami Y, Matsuda F.

    J Med Virol.   Vol. 83 ( 9 ) page: 1559-1564   2011.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  186. Clinical impact of HFE mutations in Japanese patients with chronic hepatitis C. Reviewed

    Ishizu Y, Katano Y, Honda T, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Nakano I, Goto H.

    J Gastroenterol Hepatol     2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/j.1440-1746.2011.06976

  187. Association between HCV amino acid substitutions and outcome of peginterferon andribavirin combination therapy in HCV genotype 1b and high viral load. Reviewed

    Toyoda H, Kumada T, Tada T, Arakawa T, Hayashi K, Honda T, Katano Y, Goto H.

    JGastroenterol Hepatol.   Vol. 25 ( 6 ) page: 1072-1078   2010.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  188. Impact of amino acid substitutions in the hepatitis Cvirus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C. Reviewed International journal

    Tachi Y, Katano Y, Honda T, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Nakano I, Samejima Y, Goto H.

    Liver Int.   Vol. 30 ( 4 ) page: 554-559   2010.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  189. Naofen, a novel WD40-repeatprotein, mediates spontaneous and tumor necrosis factor-induced apoptosis. Reviewed International journal

    Feng GG, Li C, Huang L, Tsunekawa K, Sato Y, Fujiwara Y, Komatsu T, Honda T,Fan JH, Goto H, Koide T, Hasegawa T, Ishikawa N.

    Biochem Biophys Res Commun.   Vol. 394 ( 1 ) page: 153-157   2010.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  190. Comparison of biochemical safety between PEG-IFN alpha-2a and PEG-IFNalpha-2b. Reviewed International journal

    Katano Y, Kumada T, Nakano I, Toyoda H, Ishigami M, Hayashi K, Honda T, Goto H.

    Hepatogastroenterology.   Vol. 56 ( 90 ) page: 485-491   2009.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  191. Mutations in the interferonsensitivity-determining region of hepatitis C virus genotype 2a correlate withresponse to pegylated-interferon-alpha 2a monotherapy. Reviewed International journal

    Hayashi K, Katano Y, Honda T, Ishigami M, Itoh A, Hirooka Y, Nakano I, Urano F, Yoshioka K, Toyoda H, Kumada T, Goto H. Mutations in the interferonsensitivity-determining region of hepatitis C virus genotype 2a correlate withresponse to pegylated-interferon-alpha 2a monotherapy.

    J Med Virol.   Vol. 81 ( 3 ) page: 459-466   2009.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  192. Correlation of serum ribavirin concentration with pretreatment renal function estimates inpatients with chronic hepatitis C receiving combination antiviral therapy withpeginterferon and ribavirin. Reviewed International journal

    Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A,Atsumi H, Nakano S, Arakawa T, Honda T, Hayashi K, Katano Y, Goto H.

    J Viral Hepat.   Vol. 15 ( 9 ) page: 651-658   2008.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  193. Regulation of branched-chain amino acid catabolism in rat models for spontaneous type 2 diabetes mellitus Reviewed International journal

    Kuzuya Teiji, Katano Yoshiaki, Nakano Isao, Hirooka Yoshiki, Itoh Akihiro, Ishigami Masatoshi, Hayashi Kazuhiko, Honda Takashi, Goto Hidemi, Fujita Yuko, Shikano Rie, Muramatsu Yuji, Bajotto Gustavo, Tamura Tomohiro, Tamura Noriko, Shimomura Yoshiharu

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   Vol. 373 ( 1 ) page: 94 - 98   2008.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.bbrc.2008.05.167

    Web of Science

  194. Use of the Model for End-Stage Liver Disease (MELD) score topredict 1-year survival of Japanese patients with cirrhosis and to determine who will benefit from living donor liver transplantation. Reviewed International journal

    Ishigami M, Honda T, Okumura A, Ishikawa T, Kobayashi M, Katano Y, FujimotoY, Kiuchi T, Goto H.

    J Gastroenterol.   Vol. 43 ( 5 ) page: 363-368   2008.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  195. Association of hepatitis B virussubgenotypes and basal core promoter/precore region variants with the clinicalfeatures of patients with acute hepatitis. Reviewed International journal

    Hayashi K, Katano Y, Takeda Y, Honda T, Ishigami M, Itoh A, Hirooka Y, NakanoI, Yoshioka K, Toyoda H, Kumada T, Goto H.

    J Gastroenterol.   Vol. 43 ( 7 ) page: 558-564   2008.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  196. *Effect of Ribavirin, Combination with Interferon in Patients with Hepatitis C, on the Bleeding Risk Associated With Selective Serotonin Reuptake Inhibitors Reviewed International journal

    Takashi Honda,Yoshiaki Katano,Hidenori Toyoda,Kazuhiko Hayashi,.Masatoshi Ishigami,Isao Nakano,Hidemi Goto,Koji Yamamoto,Junki Takamatsu

    J Clin Psychatry   Vol. 69 ( 4 ) page: 679 - 680   2008.4

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  197. Prevalence of Hepatitis E Virus IgG Antibody in Japanese Patients with Hemophilia Reviewed International journal

    Toyoda H, Honda T, Hayashi K, Katano Y, Goto H, Kumada T, Takahashi K, Abe N, Mishiro S, Takamatsu J

    Intervirology   Vol. 29 ( 51 ) page: 21-25   2008.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  198. Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma. Reviewed International journal

    Kuzuya T, Katano Y, Kumada T, Toyoda H, Nakano I, Hirooka Y, Itoh A, Ishigami M, Hayashi K, Honda T, Goto H.

    J Gastroenterol Hepatol.   Vol. 22 ( 11 ) page: 1929-1935   2007.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  199. Changes in circulating cytokine levels and lymphocyte subsets in healthy liver donors after partial hepatectomy Reviewed International journal

    Nakashima S, Katano Y, Nakano I, Hirooka Y, Ito A, Ishigami M, Hayashi K, Honda T, Goto H

    Hepatol Res.   Vol. 37 ( 10 ) page: 878-84   2007.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  200. Comparison of hepatitis B virus subgenotypes in patients with acute and chronic hepatitis B and absence of lamivudine-resistant strains in acute hepatitis B in Japan. Reviewed International journal

    Hayashi K, Katano Y, Takeda Y, Honda T, Ishigami M, Itoh A, Hirooka Y, Nakano I, Yano M, Goto H, Yoshioka K, Toyoda H, Kumada T.

    J Med Virol.   Vol. 79 ( 4 ) page: 366-373   2007.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  201. A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1B Reviewed International journal

    Murayama M, Katano Y, Nakano I, Ishigami M, Hayashi K, Honda T, Hirooka Y, Itoh A, Goto H

    J Med Virol.   Vol. 79 ( 1 ) page: 35-40   2007.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  202. Difference of HBV genotype distribution between acute hepatitis and chronic hepatitis in Japan Reviewed International journal

    Takeda Y, Katano Y, Hayashi K, Honda T, Yokozaki S, Nakano I, Yano M, Yoshioka K, Toyoda H, Kumada T, Goto H

    Infection   Vol. 34 ( 4 ) page: 201-207   2006.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  203. Mutations in carboxy-terminal part of E2 including PKR/eIF2alpha phosphorylation homology domain and interferon sensitivity determining region of nonstructural 5A of hepatitis C virus 1b: their correlation with response to interferon monotherapy and viral load Reviewed International journal

    Ukai K, Ishigami M, Yoshioka K, Kawabe N, Katano Y, Hayashi K, Honda T, Yano M, Goto H

    World J Gastroenterol.   Vol. 12 ( 23 ) page: 3722-3728   2006.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  204. Clofibrate treatment promotes branched-chain amino acid catabolism and decreases the phosphorylation state of mTOR, eIF4E-BP1, and S6K1 in rat liver Reviewed International journal

    Ishiguro H, Katano Y, Nakano I, Ishigami M, Hayashi K, Honda T, Goto H, Bajotto G, Maeda K, Shimomura Y

    Life Sci.   Vol. 79 ( 8 ) page: 737 - 743   2006.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  205. *Anti-HCV agent, ribavirin, elevates the activity of clotting factor VII in patients with hemophilia: a possible mechanism of decreased events of bleeding in patients with hemophilia by ribavirin Reviewed

    Yamamoto K, Honda T, Matsushita T, Kojima T, Takamatsu J

    J Thromb Haemost.   Vol. 4 ( 2 ) page: 469-470   2006.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  206. Treatment of chronic hepatitis C with interferon alone or combined with ribavirin in Japan Reviewed International journal

    Kumada T, Toyoda H, Honda T, Kuzuya T, Katano Y, Nakano I, Goto H

    Intervirology   Vol. 49 ( 1-2 ) page: 112-118   2006.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  207. Branched-chain amino acid catabolism in exercise and liver disease Reviewed International journal

    Shimomura Y, Honda T, Shiraki M, Murakami T, Sato J, Kobayashi H, Mawatari K, Obayashi M, Harris RA

    J Nutr.   Vol. 136 ( 1 ) page: 250S-253S   2006.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  208. Recurrent hepatocellular carcinoma with rapid growth after cardiac surgery Reviewed International journal

    Shimizu H, Katano Y, Nagano K, Yokozaki S, Shimizu F, Naito T, Hayashi K, Shimizu Y, Honda T, Kaneko T, Akita S, Nakano I, Fukuda Y

    Hepatogastroenterology   Vol. 52 ( 66 ) page: 1863-1866   2005.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  209. Clearance of GB virus C during highly active antiretroviral therapy and course of HIV disease progression in HIV-infected patients with hemophilia. Reviewed International journal

    Toyoda H, Honda T, Katano Y, Goto H, Takamatsu J

    Eur J Clin Microbiol Infect Dis.   Vol. 24 ( 9 ) page: 645-646   2005.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  210. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy Reviewed International journal

    Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kuzuya T, Honda T, Hayashi K, Nakano I, Katano Y, Goto H

    Clin Infect Dis.   Vol. 40 ( 6 ) page: e49-54   2005.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  211. *Regulation of branched-chain amino acid metabolism and pharmacological effects of branched-chain amino acids Reviewed International journal

    Shimomura Y, Murakami T, Nagasaki M, Honda T, Goto H, Kotake K, Kurokawa T, Nonami T

    Hepatol Res.   Vol. 30S   page: 3-8   2004.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  212. Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan Reviewed International journal

    Toyoda H, Hayashi K, Murakami Y, Honda T, Katano Y, Nakano I, Goto H, Kumada T, Takamatsu J

    J Med Virol.   Vol. 73 ( 2 ) page: 195-199   2004.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  213. Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000: analysis of 1365 patients in a single institution in Japan Reviewed International journal

    Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Hayashi K, Honda T, Kitabatake S, Kuzuya T, Nonogaki K, Kasugai T, Shimizu J

    Cancer   Vol. 100 ( 11 ) page: 2415 - 2421   2004.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  214. Influence of age, sex, and degree of liver fibrosis on the association between serum alanine aminotransferase levels and liver inflammation in patients with chronic hepatitis C Reviewed International journal

    Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Hayashi K, Honda T, Kuzuya T

    Dig Dis Sci.   Vol. 49 ( 2 ) page: 295-299   2004.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  215. Effects of liver failure on the enzymes in the branched-chain amino acid catabolic pathway. Biochem Biophys Res Commun Reviewed International journal

    Shimomura Y, Honda T, Goto H, Nonami T, Kurokawa T, Nagasaki M, Murakami T

    Biochem Biophys Res Commun.   Vol. 313 ( 2 ) page: 381-385   2004.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  216. *Comparison of contrast-enhanced harmonic ultrasonography and power Doppler ultrasonography for depicting vascularity of hepatocellular carcinoma identified by angiography-assisted CT Reviewed International journal

    Honda T, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Toyoda H, Ishiguro H, Ogawa S, Takeshima K, Kawachi T, Hibi T, Hayashi K, Katano Y, Fukuda Y, Goto H.

    Hepatol Res.   Vol. 27 ( 4 ) page: 314 - 321   2003.12

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  217. Characteristics and prognosis of hepatocellular carcinoma detected in sustained responders to interferon therapy for chronic hepatitis C. Reviewed International journal

    Toyoda H, Kumada T, Hayashi K, Honda T, Morita K, Nishimura D, Imada K, Imoto M, Horiguchi Y, Nakano H, Nakano I, Fukuda Y

    Cancer Detection and Prevention   Vol. 27 ( 6 ) page: 498-502   2003.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  218. Liver Damage Related with Hepatitis C and Human Immune Deficiency Coinfection Reviewed International journal

    HAYASHI K., TAKAMATSU J., HONDA T., YOKAZAKI S., NAGANO K., TOYODA H., KATANO Y., NAKANO I., FUKUDA Y., GOTO H.

    The Journal of AIDS Research   Vol. 5 ( 2 ) page: 101 - 106   2003

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:The Japanese Society for AIDS Research  

    DOI: 10.11391/aidsr1999.5.101

  219. Liver dysfunction among workers handling 5-nitro-o-toluidine Reviewed International journal

    Shimizu H, Kumada T, Nakano S, Kiriyama S, Sone Y, Honda T, Watanabe K, Nakano I, Fukuda Y, Hayakawa T

    GUT   Vol. 50 ( 2 ) page: 266 - 270   2002.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Web of Science

  220. Incidence of hepatocellular carcinoma in chronic hepatitis C after interferon therapy Reviewed International journal

    Hayashi K, Kumada T, Nakano S, Takeda I, Kiriyama S, Sone Y, Toyoda H, Shimizu H, Honda T

    HEPATO-GASTROENTEROLOGY   Vol. 49 ( 44 ) page: 508 - 512   2002

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Web of Science

  221. Analysis of hepatocellular carcinoma tumor growth detected in sustained responders to interferon in patients with chronic hepatitis C Reviewed International journal

    Toyoda H, Kumada T, Honda T, Hayashi K, Katano Y, Nakano I, Hayakawa T, Fukuda Y

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   Vol. 16 ( 10 ) page: 1131 - 1137   2001.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Web of Science

  222. Effect of the dose and duration of interferon-alpha therapy on the incidence of hepatocellular carcinoma in noncirrhotic patients with a nonsustained response to interferon for chronic hepatitis C Reviewed International journal

    Toyoda H, Kumada T, Nakano S, Takeda I, Sugiyama K, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Hayashi K, Honda T

    ONCOLOGY   Vol. 61 ( 2 ) page: 134 - 142   2001

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)  

    Web of Science

  223. Long-term follow-up of sustained responders to interferon therapy, in patients with chronic hepatitis C Reviewed International journal

    Toyoda H, Kumada T, Tokuda A, Horiguchi Y, Nakano H, Honda T, Nakano S, Hayashi K, Katano Y, Nakano I, Hayakawa T, Nishimura D, Kato K, Imada K, Imoto M, Fukuda Y

    JOURNAL OF VIRAL HEPATITIS   Vol. 7 ( 6 ) page: 414 - 419   2000.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Web of Science

▼display all

Presentations 165

  1. A HIGH FAT DIET MODULATES BILE ACID COMPOSITION AND GUT MICROBIOTA LEADING TO SEVERE CHOLANGITIS AND CIRRHOSIS IN A MURINE MODEL OF PBC International conference

    Masahiro Umemura, Akira Honda, Maho Yamashita, Takeshi Chida, Hidenao Noritake, Kenta Yamamoto, Takashi Honda, Mayuko Ichimura-Shimizu, Koichi Tsuneyama, Patrick S.C. Leung, M Eric Gershwin, Kazuhito Kawata

    AASLD2023  2023.11  AASLD2023

     More details

    Event date: 2023.11

    Language:English   Presentation type:Poster presentation  

    Venue:Boston  

  2. CHARACTERISTICS OF GUT MICROBIOTA ASSOCIATED WITH FUNCTIONAL CURE IN CHRONIC HEPATITIS B PATIENTS WITH HBEAG-NEGATIVE; POSSIBLE INHIBITION OF HEPATITIS B VIRUS BY BUTYRATE-PRODUCING BACTERIA International conference

    Takashi Honda, Asako Murayama, Yosuke Inukai, Hisanori Muto, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Norihiro Imai, Yoji Ishizu, Masatoshi Ishigami, Sachiyo Yoshio, Tetsuya Ishikawa, Hiroki Kawashima, Takanobu Kato

    AASLD2023  2023.11 

     More details

    Event date: 2023.11

    Language:English   Presentation type:Poster presentation  

    Venue:Boston  

  3. PREVALENCE OF INTRANUCLEAR LIPID DROPLETS IN NONALCOHOLIC FATTY LIVER DISEASE International conference

    Norihiro Imai, Yuki Ohsaki, Jinglei Cheng, Jingjing Zhang, Fumitaka Mizuno, Taku Tanaka, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Yoji Ishizu, Takashi Honda, Masatoshi Ishigami, Hiroaki Wake, Hiroki Kawashima

    AASLD2023  2023.11 

     More details

    Event date: 2023.11

    Language:English   Presentation type:Poster presentation  

    Venue:Boston  

  4. INTESTINAL MICROBIOME ASSOCIATED WITH EFFICACY OF ATEZOLIZUMAB AND BEVACIZUMAB THERAPY FOR HEPATOCELLULAR CARCINOMA International conference

    Yosuke Inukai, Kenta Yamamoto, Takashi Honda, Shinya Yokoyama, Takanori Ito, Norihiro Imai, Yoji Ishizu, Masanao Nakamura, Masatoshi Ishigami,Hiroki Kawashima

    AASLD2023  2023.11  AASLD2023

     More details

    Event date: 2023.11

    Language:English   Presentation type:Poster presentation  

    Venue:Boston  

  5. CLINICAL FEATURES AND OUTCOME OF LIVER INJURY INDUCED BY IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH ADVANCED MALIGNANCIES International conference

    Takanori Ito, Takafumi Yamamoto, Kazuyuki Mizuno, Shinya Yokoyama, Norihiro Imai, Kenta Yamamoto, Yoji Ishizu, Takashi Honda, Satoshi Yasuda, Hidenori Toyoda, Masatoshi Ishigami, Hiroki Kawashima

    AASLD2023  2023.11  AASLD2023

     More details

    Event date: 2023.11

    Language:Japanese   Presentation type:Poster presentation  

    Venue:Boston  

  6. CLINICAL OUTCOMES OF POROUS GLASS MEMBRANE PUMPING EMULSIFICATION DEVICE IN TRANSARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA International conference

    Fumitaka Mizuno, Norihiro Imai, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Yoji Ishizu, Takashi Honda, Masatoshi Ishigami, Hiroki Kawashima

    AASLD2023  2023.11  AASLD2023

     More details

    Event date: 2023.11

    Language:English   Presentation type:Poster presentation  

    Venue:Boston  

  7. CROSS-SECTIONAL STUDY IN GENERAL POPULATION FOR THE PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE, DISTRIBUTION OF FIBROSIS STAGE USING VIBRATION-CONTROLLED TRANSIENT ELASTOGRAPHY, AND DETERMINING THE BEST CUT OFF VALUE OF FIB-4 INDEX. International conference

    Yuji Ogawa, Wataru Tomeno, Michihiro Iwaki, Takashi Kobayashi, Asako Nogami, Takaomi Kessoku, Kazuo Notsumata, Hirotoshi Fujikawa, Kento Imajo, Masaru Baba, Miwa Kawanaka, Hideyuki Hyogo, Taku Hakamada, Takashi Honda, Miwa Tatsuta, Takato Ueno, Shigeru Mikami, Yasushi Imamura, Ken Furuya, Noriaki Manabe, Tomoari Kamada, Masato Yoneda, Takumi Kawaguchi, Satoru Saito, Atsushi Nakajima

    AASLD2023  2023.11  AASLD2023

     More details

    Event date: 2023.11

    Language:English   Presentation type:Poster presentation  

    Venue:Boston  

  8. B型慢性肝炎患者におけるエンテカビル(ETV)からテノホビル・ アラフェナミド(TAF)への切り替えによるHBs抗原減少効果の検討 -混合効果モデルを用いたトレンドシフト解析-

    本多 隆、熊田 卓、川嶋啓揮

    第45回日本肝臓学会西部会  2023.12.7 

     More details

    Event date: 2023.12

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:京都  

  9. B型慢性肝炎患者における免疫要素を加味した機能的治癒 (Functional Cure)予測因子としてのコアI97L変異の可能性

    本多 隆、石上雅敏、石川哲也

    第59回日本肝臓学会総会  2023.6.15 

     More details

    Event date: 2023.11

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:奈良  

  10. Chemokine changes before and after induction of CoreI97L mutation by IFN-based therapy in patients with chronic hepatitis B

    Takashi Honda, Masatoshi Ishigami, Hiroki Kawashima

    2023.11.3 

     More details

    Event date: 2023.11

    Language:English   Presentation type:Poster presentation  

  11. ネットワーク解析を用いた線維化マーカーと腸内細菌叢の関係性の解明

    山本 健太, 本多 隆,石上 雅敏

    第109回消化器病学会総会  2023.4.6 

     More details

    Event date: 2023.4

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Venue:長崎  

  12. HBe 抗原陰性 B 型肝炎患者における Functional cure 症例の腸内細菌の特徴

    本多 隆、石上雅敏、川嶋啓揮

    第109回消化器病学会総会  2023.4.8 

     More details

    Event date: 2023.4

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Venue:長崎  

  13. USEFULNESS OF MUTATIONS INDUCED IN THE CORE REGION BY INTERFERON-BASED THERAPY International conference

    Takashi Honda, Masatoshi Ishigami, Asuka Kato, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Norihiro Imai, Yoji Ishizu, Satoshi Yasuda, Hidenori Toyoda, Takashi Kumada, Tetsuya Ishikawa, Hiroki Kawashima

    2022.11.4 

     More details

    Event date: 2022.11

    Language:English   Presentation type:Poster presentation  

    Venue:Washington D.C.  

  14. PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE AND DISTRIBUTION OF EACH FIBROSIS STAGE USING VIBRATION-CONTROLLED TRANSIENT ELASTOGRAPHY International conference

    Yuji Ogawa, Asako Nogami, Takaomi Kessoku, Kazuo Notsumata, Hirotoshi Fujikawa, Wataru Tomeno, Kento Imajo, Masaru Baba, Miwa Kawanaka, Hideyuki Hyogo, Taku Hakamada, Takashi Honda, Miwa Tatsuta, Takato Ueno, Shigeru Mikami, Yasushi Imamura, Ken Furuya, Masato Yoneda, Takumi Kawaguchi, Satoru Saito, Prof. Atsushi Nakajima, Tatsuji Komatsu

    AASLD2022  2022.11  AASLD2022

     More details

    Event date: 2022.11

    Language:English   Presentation type:Poster presentation  

    Venue:Washington D.C.  

  15. CLINICAL COURSE AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HEMOPHILIA International conference

    Norihiro Imai, Masatoshi Ishigami, Noritaka Matsuda, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Yoji Ishizu, Takashi Honda, Hiroki Kawashima

    AASLD2022  2022.11 

     More details

    Event date: 2022.11

    Language:English   Presentation type:Poster presentation  

  16. ANOREXIA IS ASSOCIATED WITH THE PRESENCE OF SARCOPENIA IN PATIENTS WITH CIRRHOSIS International conference

    Yoji Ishizu, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Norihiro Imai, Takashi Honda Honda, Masatoshi Ishigami and Hiroki Kawashima

    AASLD2022  2022.11 

     More details

    Event date: 2022.11

    Language:English   Presentation type:Poster presentation  

  17. B型肝炎のFunctional cureを目指したインターフェロン治療の効果とコア領域の変異測定の有用性

    本多隆, 豊田秀徳, 安田諭, 横山晋也, 山本健太, 伊藤隆徳, 今井則博, 石津洋二, 石川哲也, 石上雅敏

    JDDW2022  2022.10.28 

     More details

    Event date: 2022.10

    Language:Japanese   Presentation type:Poster presentation  

    Venue:福岡  

  18. B型慢性肝炎患者における機能的治癒(Functional Cure)症例の特徴とコアI97L変異の関係

    本多隆, 加藤孝宣, 石上雅敏

    第58回日本肝臓学会総会  2022.6.2  日本肝臓学会

     More details

    Event date: 2022.6

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Venue:横浜  

  19. B型慢性肝炎患者における機能的治癒(Functional Cure)予測因子としてのコアI97L変異の可能性

    本多隆, 加藤孝宜, 石上雅敏

    第108回消化器病学会総会  2022.4.21  消化器病学会

     More details

    Event date: 2022.4

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

  20. Possible prediction of functional cure by HBV core mutations in patients with chronic hepatitis B

    Takashi Honda, Masatoshi Ishigami, Takafumi Yamamoto, Yosuke Inukai, Yoshiaki Sugiyama, Naoki Yoshioka, Kazuhiro Mizuno, Hisanori Muto, Shinya Yokoyama, Taku Tanaka, Kenta Yamamoto, Takanori Ito, Norihiro Imai, Yoji Ishizu, Mitsuhiro Fujishiro

    2021.11.4 

     More details

    Event date: 2021.11

    Language:English   Presentation type:Poster presentation  

  21. 多孔質ガラス膜-薬液混合コネクタを用いた肝動脈化学塞栓術の治療成績

    今井則博、山本 健太、伊藤 隆徳、石津 洋二、本多 隆、石上 正敏、藤城 光弘

    JDDW2021  2021.11.4  肝臓学会

     More details

    Event date: 2021.11

    Language:Japanese   Presentation type:Poster presentation  

    Venue:神戸   Country:Japan  

  22. Rifaximin投与患者におけるアンモニア測定の意義

    石津 洋二、石上 正敏、山本 崇文、犬飼 庸介、杉山 由晃、吉岡 直輝、水野 和幸、武藤 久哲、横山 晋也、山本 健太、伊藤 隆徳、今井則博、本多 隆、藤城 光弘

    JDDW2021  2021.11.4  肝臓学会

     More details

    Event date: 2021.11

    Language:Japanese   Presentation type:Poster presentation  

    Venue:神戸  

  23. 慢性肝疾患患者における筋肉量,血清分岐鎖アミノ酸濃度,細菌叢の相関に関する検討

    山本 健太、本多 隆、藤城 光弘

    JDDW2021  2021.11.4  肝臓学会

     More details

    Event date: 2021.11

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Venue:神戸   Country:Japan  

  24. Usefulness of core I97L in predicting the efficacy of nucleos(t)ide analogue therapy in patients with hepatitis B International conference

    Takashi Honda, Masatoshi Ishigami, Kenta Yamamoto, Takanori Ito, Norihiro Imai, Yoji Ishizu, Mitsuhiro Fujishiro

    AASLD2021  2021.11 

     More details

    Event date: 2021.11

    Language:English   Presentation type:Poster presentation  

    Country:United States  

  25. Differences in the intestinal microbiome associated with diarrhea during lenvatinib treatment for hepatocellular carcinoma International conference

    Yosuke Inukai, Kenta Yamamoto, Takashi Honda, Takanori Ito, Norihiro Imai, Yoji Ishizu, Masanao Nakamura, Hiroki Kawashima, Masatoshi Ishigami, Mitsuhiro Fujishiro

    AASLD2021  2021.11 

     More details

    Event date: 2021.11

    Language:English   Presentation type:Poster presentation  

    Country:United States  

  26. The impact of hepatitis C virus eradication on hepatocarcinogenesis in haemophiliacs International conference

    Inukai Yosuke, Imai Norihiro, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Honda Takashi, Ishigami Masatoshi

    EASL2021  2021.7 

     More details

    Event date: 2021.7

    Language:English   Presentation type:Poster presentation  

  27. 肝硬変による入院イベントと腸内細菌叢の関連性

    山本健太、本多 隆、山本 崇文、犬飼 庸介、杉山 由晃、吉岡 直輝、水野 和幸、武藤 久哲、横山 晋也、伊藤 隆徳、今井則博、石津 洋二、石上 正敏、藤城 光弘

    第57回日本肝臓学会総会  2021.6.18  肝臓学会

     More details

    Event date: 2021.6

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:北海道(Web)   Country:Japan  

  28. 核酸アナログ治療中止可能予測因子とHBVコア変異の関係

    本多 隆、石上 雅敏、山本 崇文、犬飼 庸介、杉山 由晃、吉岡 直輝、水野 和幸、武藤 久哲、横山 晋也、山本 健太、伊藤 隆徳、今井則博、石津 洋二、石川 哲也、藤城 光弘

    第57回日本肝臓学会総会  2021.6.18  肝臓学会

     More details

    Event date: 2021.6

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:北海道(Web)   Country:Japan  

  29. Functional cureに関与するコア領域のアミノ酸変異がHBVライフサイクルに与える影響の解析

    加藤 孝宣、山田 典栄、本多 隆

    第57回日本肝臓学会総会  2021.6.1 

     More details

    Event date: 2021.6

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Venue:北海道(Web)   Country:Japan  

  30. The impact of hepatitis C virus eradication on hepatocarcinogenesis in haemophiliacs International conference

    Yosuke Inukai, Norihiro Imai, Kenta Yamamoto, Takanori Ito, Yoji Ishizu, Takashi Honda, Masatoshi Ishigami,Mitsuhiro Fujishiro

    2021.6 

     More details

    Event date: 2021.6

    Language:English   Presentation type:Poster presentation  

  31. 慢性肝疾患患者における生活習慣・排便状況調査と腸内細菌叢に与える影響

    山本 健太、本多 隆、藤城 光弘

    第107回消化器病学会総会  2021.4.17  消化器病学会

     More details

    Event date: 2021.4

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Venue:東京(Web)   Country:Japan  

  32. B型慢性肝炎におけるFunctional cureに関連するHBVコア変異

    本多 隆、加藤 孝宣、藤城 光弘

    第107回消化器病学会総会   2021.4.15  消化器病学会

     More details

    Event date: 2021.4

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Venue:東京(Web)   Country:Japan  

  33. 肝硬変患者に対する分岐アミノ酸投与による腸内細菌叢の違い

    犬飼庸介、本多 隆、山本健太、山本崇文、杉山由晃、吉岡直輝、水野和幸、武藤久哲、横山晋也、田中 卓、伊藤隆徳、石津洋二、葛谷貞二、石上正敏、藤城光弘

    JDDW2020  2020.11 

     More details

    Event date: 2020.11

    Language:Japanese   Presentation type:Poster presentation  

  34. 非肝癌症例と肝発癌症例の違いに関与する腸内細菌の検討

    本多 隆, 石上 雅敏, 山本 崇文, 犬飼 庸介, 杉山 由晃, 吉岡 直輝, 水野 和幸, 武藤 久哲, 横山 晋也, 田中 卓, 山本 健太, 伊藤 隆徳, 石津 洋二, 葛谷 貞二, 石川 哲也, 藤城 光弘

    JDDW2020  2020.11 

     More details

    Event date: 2020.11

    Language:Japanese   Presentation type:Poster presentation  

  35. SAFETY AND EFFICACY OF PERCUTANEOUS RADIOFREQUENCY ABLATION FOR HEPATOCELLULAR CARCINOMA PATIENTS WITH HEMOPHILIA International conference

    Yamamoto Takafumi, Ishigami Masatoshi, Yamamoto Kenta, Ito Takanori, Imai Norihiro, Lshizu Yoji, Honda Takashi, Fujishiro Mitsuhiro

    AASLD2020  2020.11 

     More details

    Event date: 2020.11

    Language:English   Presentation type:Poster presentation  

  36. AMINO ACID POLYMORPHISM IN HEPATITIS B VIRUS ASSOCIATED WITH NATURAL CLEARANCE OF HBV DNA AND HBsAg International conference

    Honda Takashi, Yamada None, Murayama Asako, Kato Asuka, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Ishigami Masatoshi, Murakami Yoshiki, Ishikawa Tetsuya, Fujishiro Mitsuhiro, Kato Takanobu

    AASLD2020  2020.11 

     More details

    Event date: 2020.11

    Language:English   Presentation type:Poster presentation  

  37. IMPROVEMENT OF LIVER FUNCTIONAL RESERVE AFTER SVR IN HCV-PATIENTS WITH COMPENSATED, SEVERE FIBROSIS BY IFN-FREE, DAA COMBINATION TREATMENT-IMPACT OF PRETREATMENT SERUM AFP LEVELS International conference

    Ishigami Masatoshi, Honda Takashi, Ishizu Yoji, Imai Norihiro, Ito Takanori, Yamamoto Kenta, Fujishiro Mitsuhiro

    AASLD2020  2020.11 

     More details

    Event date: 2020.11

    Language:English   Presentation type:Poster presentation  

  38. GUT MICROBIOTA ASSOCIATED WITH THE DIFFERENCE BETWEEN PATIENTS WITH AND WITHOUT HEPATOCELLULAR CARCINOMA IN CHRONIC LIVER DISEASE International conference

    Honda Takashi, Ishigami Masatoshi, Yamamoto Kenta, Ito Takanori, Imai Norihiro, Ishizu Yoji, Fujishiro Mitsuhiro

    AASLD2020  2020.11 

     More details

    Event date: 2020.11

    Language:English   Presentation type:Poster presentation  

  39. B型肝炎患者におけるFunctional cureと腸内細菌の関係

    本多 隆、石上雅敏、藤城光弘

    第106回消化器病学会総会  2020.8.11 

     More details

    Event date: 2020.8

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

  40. 慢性肝疾患患者における腸内細菌叢のPredicted Functional Dysbiosisに影響を与える因子についての検討

    山本健太、本多 隆、石上雅敏

    第56回日本肝臓学会総会  2020.5.22 

     More details

    Event date: 2020.5

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

  41. B型肝炎症例におけるテノホビル ジソプロキシルフマル酸塩への切替えによるHBV DNA、HBs抗原、 ALT値の変化に関する検討

    本多 隆, 石上雅敏, 山本崇文, 犬飼庸介, 吉岡直輝, 水野和幸, 武藤久哲, 横山晋也, 田中卓, 山本健太, 伊藤隆徳, 石津洋二, 葛谷貞二, 石川哲也, 藤城光弘

    第56回日本肝臓学会総会  2020.5.22  第56回日本肝臓学会総会

     More details

    Event date: 2020.5

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:大阪  

  42. ASSOCIATION BETWEEN FASTING BREATH HYDROGEN LEVELS AND PANCREATIC EXOCRINE INEFFICIENCY International conference

    Uetsuki Kota, Kawashima Hiroki, Ohno Eizaburo, Ishikawa Takuya, Nakamura Masanao, Furukawa Kazuhiro, Ishigami Masatoshi, Honda Takashi, Fujishiro Mitsuhiro

    AGA2020  2020.5 

     More details

    Event date: 2020.5

    Language:English   Presentation type:Poster presentation  

  43. EXAMINATION OF NEW PREDICTIVE FACTORS USING ENDOSCOPY AND SERUM CYTOKINE LEVELS FOR USTEKINUMAB IN CROHN'S DISEASE International conference

    Murate Kentaro, Maeda Keiko, Nakamura Masanao, Sugiyama Daisuke, Wada Hirotaka, Yamamura Takeshi, Sawada Tsunaki, Mizutani Yasuyuki, Ishikawa Takuya, Furukawa Kazuhiro, Ohno Eizaburo, Honda Takashi, Kawashima Hiroki, Ishigami Masatoshi, Nishikawa Hiriyoshi, Fujishiro Mitsuhiro

    AGA2020  2020.5 

     More details

    Event date: 2020.5

    Language:English   Presentation type:Poster presentation  

  44. QUANTITATIVE EVALUATION OF TREATMENT EFFECT USING SHEAR WAVE ELASTOGRAPHY AND SHEAR WAVE DISPERSION IN AUTOIMMUNE PANCREATITIS International conference

    Suzuki Hirotaka, Kawashima Hiroki, Ohno Eizaburo, Ishikawa Takuya, Nakamura Masanao, Furukawa Kazuhiro, Ishigami Masatoshi, Honda Takashi, Fujishiro Mitsuhiro

    AGA2020  2020.5 

     More details

    Event date: 2020.5

    Language:English   Presentation type:Poster presentation  

  45. C型肝癌症例に関連する腸内細菌の検討

    JDDW2019  2019.11.21 

     More details

    Event date: 2019.11

    Language:Japanese   Presentation type:Poster presentation  

  46. UTILITY OF THE ALBUMIN-BILIRUBIN SCORE FOR PREDICTING PROGNOSIS IN JAPANESE PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: AN ANALYSIS USING TIME-DEPENDENT RECEIVER OPERATING CHARACTERISTICS International conference

    Ito Takanori, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Yasuda Satoshi, Toyoda Hidenori, Kumada Takashi, Fujishiro Mitsuhiro

    AASLD2019  2019.10 

     More details

    Event date: 2019.10

    Language:English   Presentation type:Poster presentation  

  47. CHANGES OF MICROBIOTA AFTER HEPATITIS C VIRUS ERADICATION International conference

    Honda Takashi, Ishigami Masatoshi, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Fujishiro Mitsuhiro

    AASLD2019  2019.10 

     More details

    Event date: 2019.10

    Language:English   Presentation type:Poster presentation  

  48. NON-INVASIVE SCREENING FOR DETECTING ESOPHAGOGASTRIC VARICES IN CHILDREN WITH BILIARY ATRESIA International conference

    Yokoyama Shinya, Ishigami Masatoshi, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Ito Takanori, Shirota Chiyoe, Uchida Hiroo, Fujishiro Mitsuhiro

    AASLD2019  2019.10 

     More details

    Event date: 2019.10

    Language:English   Presentation type:Poster presentation  

  49. INDICATION FOR HCC TREATMENT IN RECENT ERA-PROPOSAL OF THE NEW PRIORITY FOR LIVER TRANSPLANTATION IN PATIENTS WITH HCC International conference

    Ishigami Masatoshi, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Ito Takanori, Fujishiro Mitsuhiro

    AASLD2019  2019.10 

     More details

    Event date: 2019.10

    Language:English   Presentation type:Poster presentation  

  50. The relationship between portal hypertension and the microbiome International conference

    Yamamoto K., Honda T., Hattori S., Pu L. Zorron Cheng Tao, Ito T., Yamamura T., Ishizu Y., Kuzuya T., Ishigami M., Fujishiro M.

    AGW2019  2019.9 

     More details

    Event date: 2019.9

    Language:English   Presentation type:Poster presentation  

  51. Specific members of gut microbiota predict mucosal healing in Crohn's disease International conference

    Hattori S., Nakamura M., Yamamura T., Maeda K., Sawada T., Mizutani Y., Yamamoto K., Pu L. Zorron Cheng Tao, Honda T., Ishikawa T., Furukawa K., Ohno E., Miyahara R., Kawashima H., Fujishiro M.

    AGW2019  2019.9 

     More details

    Event date: 2019.9

    Language:English   Presentation type:Poster presentation  

  52. Microbiota profile is markedly different for early and invasive colorectal cancer and is consistent throughout the colon International coauthorship International conference

    Pu L. Zorron Cheng Tao, Yamamoto K., Honda T., Hattori S., Nakamura M., Yamamura T., Burt A., Hirooka Y., Singh R., Fujishiro M.

    AGW2019  2019.9 

     More details

    Event date: 2019.9

    Language:English   Presentation type:Poster presentation  

  53. 核酸アナログ治療症例におけるHBVcore変異とウイルス量、HBsAg、HBcrAgの関係

    本多 隆、石上雅敏、藤城光弘

    肝臓学会総会  2019.5.30 

     More details

    Event date: 2019.5

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  54. 慢性肝疾患例における肝発癌症例に関連する腸内細菌叢の検討

    本多 隆、石上雅敏、廣岡芳樹

    消化器病学会総会  2019.5.9 

     More details

    Event date: 2019.5

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Country:Japan  

  55. The optimal cut-off points of FIB-4 index for predicting the incidences of HCC and extra-hepatic malignancies in biopsyproven Japanese NAFLD patients International conference

    Ito Takanori, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Fujishiro Mitsuhiro

    EASL2019  2019.4 

     More details

    Event date: 2019.4

    Language:English   Presentation type:Poster presentation  

  56. The early clinical response at 2 weeks of lenvatinib therapy for patients with advanced HCC International conference

    Kuzuya Teiji, Ishigami Masatoshi, Ito Takanori, Ishizu Yoji, Honda Takashi, Fujishiro Mitsuhiro

    EASL2019  2019.4 

     More details

    Event date: 2019.4

    Language:English   Presentation type:Poster presentation  

  57. Serum Zinc levels as a prognostic factor for extra-hepatic carcinogenesis in Japanese patients with non-alcoholic liver disease International conference

    Ito Takanori, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Fujishiro Mitsuhiro

    EASL2019  2019.4 

     More details

    Event date: 2019.4

    Language:English   Presentation type:Oral presentation (general)  

  58. Association between gut microbiota and hepatocellular carcinoma in patients with chronic liver disease International conference

    Honda Takashi, Ishigami Masatoshi, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Fujishiro Mitsuhiro

    EASL2019  2019.4 

     More details

    Event date: 2019.4

    Language:English   Presentation type:Poster presentation  

  59. Association between Core Mutations Induced By Interferon Therapy and Annual Decline Rate of Hbvdna in Chronic Hepatitis B Patients International conference

    Takashi Honda, Masatoshi Ishigami, Takanori Ito, Yoji Ishizu, Teiji Kuzuya and Yoshiki Hirooka,

    AASLD2018  2018.11.12 

     More details

    Event date: 2018.11

    Language:English   Presentation type:Poster presentation  

  60. 自然経過及び治療症例におけるHBVcoreI97L変異とウイルス量,HBsAg減少の関係

    本多 隆、石上雅敏、廣岡芳樹

    JDDW2018  2018.11.12 

     More details

    Event date: 2018.11

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Venue:神戸   Country:Japan  

  61. C型肝炎ウイルス駆除による腸内細菌叢への影響

    本多 隆、石上雅敏、廣岡芳樹

    JDDW2018  2018.11.1 

     More details

    Event date: 2018.11

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

  62. Novel Candidate Drugs That Target Cccdna of HBV International conference

    Murakami Yoshiki, Hayakawa Michiyo, Itami-Matsumoto Saari, Ando Mari, Yata Yutaka, Enomoto Masaru, Tamori Akihiro, Kawada Norifumi, Honda Takashi, Yano Yoshihiko, Iwadate Mitsuo, Umeyama Hideaki

    AASLD2018  2018.10 

     More details

    Event date: 2018.10

    Language:English   Presentation type:Poster presentation  

  63. Late Relapse and Molecular Analysis of Hepatitis C Virus in Patients with Sustained Virological Response By All Oral Direct Acting Antivirals Therapy International conference

    Hayashi Kazuhiko, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Ishigami Masatoshi, Shimizu Yuko, Tachi Kousuke, Goto Hidemi

    AASLD2018  2018.10 

     More details

    Event date: 2018.10

    Language:English   Presentation type:Poster presentation  

  64. Interferon-Free Antiviral Therapy Rapidly Improves Thrombocytopenia in Patients with Advanced Chronic Hepatitis C International conference

    Ishizu Yoji, Ishigami Masatoshi, Ito Takanori, Kuzuya Teiji, Honda Takashi, Hirooka Yoshiki

    AASLD2018  2018.10 

     More details

    Event date: 2018.10

    Language:English   Presentation type:Poster presentation  

  65. Comparison of Gut Microbiota and Predicted Functional Metagenome in Hepatitis C Patients with and without Advanced Fibrosis Categorized By FIB4-Index International conference

    Yamamoto Kenta, Ishigami Masatoshi, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Hirooka Yoshiki

    AASLD2018  2018.10 

     More details

    Event date: 2018.10

    Language:English   Presentation type:Poster presentation  

  66. Association between Core Mutations Induced By Interferon Therapy and Annual Decline Rate of Hbvdna in Chronic Hepatitis B Patients International conference

    Honda Takashi, Ishigami Masatoshi, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Hirooka Yoshiki

    AASLD2018  2018.10 

     More details

    Event date: 2018.10

    Language:English   Presentation type:Poster presentation  

  67. インターフェロン治療によるHBV core I97L変異の 誘導とHBV DNA及びHBsAg減少率に関する検討

    本多 隆、石上雅敏、後藤秀実

    第54回日本肝臓学会総会  2018.6.14 

     More details

    Event date: 2018.6

    Language:Japanese   Presentation type:Oral presentation (general)  

  68. C型肝炎ウイルスの肝病態による腸内細菌叢の違いと駆除後の肝癌発症との関連

    本多 隆、石上雅敏、廣岡芳樹

    肝臓学会総会  2018.6.14 

     More details

    Event date: 2018.6

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Country:Japan  

  69. C型肝炎による肝発癌に関連する腸内細菌叢の検討

    本多 隆、廣岡芳樹、後藤秀実

    消化器病学会総会  2018.4.20 

     More details

    Event date: 2018.4

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

  70. Naturally occurring drug resitance substitutions in the NS5A and NS5B regions in Hepatitis C virus genotype 2 and response to sofosbuvir plus ribavirin therapy International conference

    Hayashi K., Ishigami M., Ishizu Y., Kazuya T., Honda T., Hirooka Y., Goto H.

    EASL2018  2018.4 

     More details

    Event date: 2018.4

    Language:English   Presentation type:Poster presentation  

  71. Secreted ectodomain of SIGLEC-9 and MCP-1 ameliorate acute liver failure in rats by altering bone marrow macrophage polarity International conference

    Ito T., Ishigami M., Yamamoto A., Ishizu Y., Kazuya T., Honda T., Hayashi K., Ishikawa T., Hirooka Y., Goto H.

    EASL2018  2018.4 

     More details

    Event date: 2018.4

    Language:English   Presentation type:Poster presentation  

  72. Utility and limitation of non-invasive fibrosis markers for predicting the prognosis in biopsy-proven Japanese NAFLD patients International conference

    Ito T., Ishigami M., Ishizu Y., Kazuya T., Honda T., Hayashi K., Ishikawa T., Hirooka Y., Goto H.

    EASL2018  2018.4 

     More details

    Event date: 2018.4

    Language:English   Presentation type:Poster presentation  

  73. Prognostic factors related to post-progression survival in advanced hepatocellular carcinoma patients treated with sorafenib not eligible for second-line regorafenib treatment Teiji Kuzuya* 1, Masatoshi Ishigami1, Takanori Ito1, Yoji Ishizu1"

    Kuzuya T, Ishigami M, Ito T, Ishizu Y, Honda T, Hirooka Y

    ILCA2018  2018 

     More details

    Event date: 2018

    Language:English   Presentation type:Poster presentation  

    Venue:London  

  74. Association between microbiome and hepatitis C virus-infected patients with hepatocellular carcinoma International conference

    Honda T, Ishigami M, Yamamoto K, Ito T, Ishizu Y, Kuzuya T, Hirooka Y

    ILCA2018  2018 

     More details

    Event date: 2018

    Language:English   Presentation type:Poster presentation  

    Venue:London  

  75. Daclatasvir and asunaprevir treatment in patients with severe liver fibrosis by hepatitis C virus genotype 1b infection: Real-world data International conference

    Ishigami Masatoshi, Hayashi Kazuhiko, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Ishikawa Tetsuya, Nakano Isao, Urano Fumihiro, Kumada Takashi, Yoshioka Kentaro, Goto Hidemi, Hirooka Yoshiki

    APASL  2017.11 

     More details

    Event date: 2017.11

    Language:English   Presentation type:Poster presentation  

  76. B型慢性肝炎におけるインターフェロン治療効果とcoreI97L変異によるその後の肝炎沈静化の予測

    本多隆、石上雅敏、後藤秀実

    JDDW2017  2017.10.12 

     More details

    Event date: 2017.10

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Country:Japan  

  77. 非B非C肝癌における肝発癌に関連する腸内細菌叢の検討

    本多隆

    JDDW2017  2017.10.12 

     More details

    Event date: 2017.10

    Language:Japanese   Presentation type:Poster presentation  

    Country:Japan  

  78. Core I97LとP79Qの変異はB型慢性肝炎患者において持続HBVDNA低値とHBs抗原消失に関与する

    本多 隆、石上雅敏、後藤秀実

    第53回日本肝臓学会総会  2017.6.8 

     More details

    Event date: 2017.6

    Language:Japanese   Presentation type:Oral presentation (general)  

  79. The Impact of Hepatitis B Virus Infection on Sustained Virologic Response and HBV Reactivation in Patients with Chronic Hepatitis C who Treated by all-Oral Direct-Acting Antivirals Regimens International conference

    Hayashi K, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hirooka Y, Goto H

    DDW2017  2017 

     More details

    Event date: 2017

    Language:English   Presentation type:Poster presentation  

    Venue:Chicago  

  80. The Association Between Amino Acid Substitutions in the NS5A Region of Hepatitis C Virus and Development of Hepatocellular Carcinoma After Sustained Virological Response International conference

    Yashuda S, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Hirooka Y, Goto H"

    DDW2017  2017 

     More details

    Event date: 2017

    Language:English   Presentation type:Poster presentation  

    Venue:Chicago  

  81. B型慢性肝炎におけるインターフェロン治療効果とCoreI97L変異による治療効果の予測

    本多隆

    JDDW2016  2016.11.2 

     More details

    Event date: 2016.11

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  82. Relation between core mutations and HBVDNA, HBsAg decreasing rate in the patients with chronic hepatitis B International conference

    Takashi Honda

    APDDW2016  2016.11.2 

     More details

    Event date: 2016.11

    Language:English   Presentation type:Poster presentation  

    Country:Japan  

  83. Revisiting the prognosis after liver transplantation in HCV-positive patients-focus on HCV-unrelated complications International conference

    Ishigami Masatoshi, Hayashi Kazuhiko, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Hirooka Yoshiki, Goto Hidemi

    APASL2016  2016.11 

     More details

    Event date: 2016.11

    Language:English   Presentation type:Poster presentation  

  84. Treatment for elderly patients with hepatitis C Invited International conference

    Takashi Honda, Masatoshi Ishigami, Kazuhiko Hayashi, Hidemi Goto

    3rd International Monothematic Conference on Viral Hepatitis C   2016.9.29 

     More details

    Event date: 2016.9

    Language:English   Presentation type:Oral presentation (invited, special)  

    Country:Croatia  

  85. コリン欠乏高脂肪食によるNASHマウスモデルにおける分岐鎖アミノ酸投与による糖質、アミノ酸代謝の変化

    本多 隆、石上雅敏、山本健太、安藤祐資、安田 諭、伊藤隆徳、野村 彩、加藤幸一郎、新家卓郎、石津洋二、葛谷貞二、林 和彦、廣岡芳樹、石川哲也、中野功、後藤秀実

    第3回肝臓と糖尿病代謝研究会  2016.7.16 

     More details

    Event date: 2016.7

    Language:Japanese  

  86. Efficacy of dual oral therapy with asunaprevir and daclatasvir for elderly patients with hepatitis C International conference

    Honda T, Ishigami M , Ishizu Y, Kuzuya T, Hayashi K, Hirooka Y, Goto H

    HCVmeeting2016  2016.7.7 

     More details

    Event date: 2016.7

    Language:English   Presentation type:Poster presentation  

    Country:Japan  

  87. Core I97L mutation is associated with persistent low HBV DNA and HBsAg clearance in patients with chronic hepatitis B International conference

    Takashi Honda, Masatoshi Ishigami, Yoji Ishizu, Teiji Kuzuya, Kazuhiko Hayashi, Yoshiki Hirooka, Hidemi Goto

    DDW2016  2016.5.24 

     More details

    Event date: 2016.5

    Language:English   Presentation type:Poster presentation  

    Country:United States  

  88. B型慢性肝炎におけるcoreI97L変異とHBV DNA減少及びHBs抗原の消失に関する検討

    本多 隆、石上雅敏、後藤秀実

    第52回日本肝臓学会総会  2016.5.19 

     More details

    Event date: 2016.5

    Language:Japanese   Presentation type:Oral presentation (general)  

  89. HBs抗原消失がみられI97L変異の長期観察ができた症例の検討

    本多隆

    第101回日本消化器病学会総会  2016.4.23 

     More details

    Event date: 2016.4

    Language:Japanese   Presentation type:Poster presentation  

    Venue:東京   Country:Japan  

  90. B型慢性肝炎におけるcoreI97L変異による持続HBV DNA低値ALT正常及びHBs抗原消失の予測

    本多 隆、石上雅敏、後藤秀実

    第41回日本肝臓学会西部会  2015.12.4 

     More details

    Event date: 2015.12

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Venue:名古屋   Country:Japan  

  91. 高齢者C型慢性肝炎におけるDaclatasvir /Asunaprevir併用療法の早期反応と治療効果

    本多 隆、石上雅敏、安藤祐資、安田 諭、伊藤隆徳、川口 彩、加藤幸一郎、新家卓郎、今井則博、阿知波宏一、石津洋二、葛谷貞二、林 和彦、石川哲也、中野 功、後藤秀実

    第41回日本肝臓学会西部会  2015.12.4 

     More details

    Event date: 2015.12

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  92. Early response and efficacy of dual oral therapy with asunaprevir and daclatasvir for elderly patients with hepatitis C International conference

    Takashi Honda, Masatoshi Ishigami, Yoji Ishizu, Teiji Kuzuya, Kazuhiko Hayashi, Yoshiki Hirooka, Hidemi Goto

    AASLD2015  2015.11.15 

     More details

    Event date: 2015.11

    Language:English   Presentation type:Poster presentation  

    Country:Japan  

  93. B型慢性肝炎におけるHBVDNA及びHBs抗原減少に関与するウイルス遺伝子変異の検討

    本多 隆、石上雅敏、後藤秀実

    JDDW2015  2015.10.8 

     More details

    Event date: 2015.10

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Venue:東京   Country:Japan  

  94. DSS colitis has tumorinogenesis and fibrogenesis in choline-deficiency and high-fat diet induced NASH mouse model International conference

    Achiwa Koichi, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Hayashi Kazuhiko, Hirooka Yoshiki, Goto Hidemi

    AASLD2015  2015.10 

     More details

    Event date: 2015.10

    Language:English  

  95. The relationship between the fever within 6 weeks after the start of sorafenib therapy and the outcome for patients with advanced hepatocellular carcinoma International conference

    Kuzuya Teiji, Ishigami Masatoshi, Ishizu Yoji, Honda Takashi, Hayashi Kazuhiko, Goto Hidemi

    AASLD2015  2015.10 

     More details

    Event date: 2015.10

    Language:English   Presentation type:Poster presentation  

  96. A comparison of direct sequencing and PCR-invader assay for the detection of NS5A Y93H mutation and response to daclatasvir and asunaprevir therapy in patients with hepatitis C virus genotype 1b International conference

    Hayashi Kazuhiko, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Hirooka Yoshiki, Goto Hidemi

    AASLD2015  2015.10 

     More details

    Event date: 2015.10

    Language:English   Presentation type:Oral presentation (general)  

  97. コリン欠乏高脂肪食による高血糖を伴わないNASHマウスモデルにおける脂質、分岐鎖アミノ酸代謝の検討

    本多 隆、石上雅敏、伊藤隆徳、安田 諭、川口 彩、加藤幸一郎、新家卓郎、今井則博、阿知波宏一、石津洋二、葛谷貞二、林 和彦、中野 功、石川哲也、片野義明、後藤秀実

    第2回肝臓と糖尿病代謝研究会  2015.5.23 

     More details

    Event date: 2015.5

    Language:Japanese   Presentation type:Poster presentation  

    Venue:下関   Country:Japan  

  98. 高齢者C型肝炎におけるDaclatasvir・Asunaprevir併用療法の治療早期の効果

    本多 隆、石上雅敏、新家卓郎、今井則博、阿知波宏一、荒川恭宏、山田恵一、中野 聡、石津洋二、葛谷貞二、林 和彦、中野 功、石川哲也、片野義明、後藤秀実

    第51回日本肝臓学会総会  2015.5.21 

     More details

    Event date: 2015.5

    Language:Japanese   Presentation type:Poster presentation  

    Venue:熊本   Country:Japan  

  99. B型慢性肝炎におけるcoreI97変異がその後の経過に及ぼす影響

    本多 隆、石上雅敏、川口 彩、加藤幸一郎、新家卓郎、今井則博、阿知波宏一、山田恵一、石津洋二、葛谷貞二、林 和彦、石川哲也、中野 功、後藤秀実

    第101回日本消化器病学会総会  2015.4.23 

     More details

    Event date: 2015.4

    Language:Japanese   Presentation type:Oral presentation (general)  

  100. The Prevalence of Naturally Occurring Resistance Mutations Against Direct Acting Antivirals in Patients With Hepatitis C Virus Genotype 1b and Response to Interferon Based Therapy International conference

    Hayashi Kazuhiko, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Katano Yoshiaki, Goto Hidemi

    DDW2015  2015.4 

     More details

    Event date: 2015.4

    Language:English   Presentation type:Poster presentation  

  101. B型肝炎における経過予測及びHBs抗原消失に関与するウイルス遺伝子変異

    本多 隆、石上雅敏、後藤秀実

    第40回日本肝臓学会東部会  2014.11.27 

     More details

    Event date: 2014.11

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Country:Japan  

  102. Oral supplementation of BCAA alleviates hepatic steatosis and liver injury associated with NASH International conference

    Takashi Honda, Masatoshi Ishigami, Fangqiong Luo, Yoji Ishizu, Teiji Kuzuya, Kazuhiko Hayashi, Yoshiharu Shimomura, and Hidemi Goto

    AASLD2014  2014.11.9 

     More details

    Event date: 2014.11

    Language:English   Presentation type:Oral presentation (general)  

    Country:United States  

  103. Reactivation of hepatitis B virus in patients without hepatitis B surface antigen treated with immunosuppressive or chemotherapy International conference

    Hayashi Kazuhiko, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Katano Yoshiaki, Hirooka Yoshiki, Goto Hidemi

    APASL2014  2014.11 

     More details

    Event date: 2014.11

    Language:English   Presentation type:Poster presentation  

  104. 高齢者C型慢性肝炎におけるPegIFN・Ribavirin・Simeprevir3剤併用療法の治療効果

    本多 隆、石上雅敏、加藤幸一郎、新家卓郎、今井則博、阿知波宏一、荒川恭宏、山田恵一、石津洋二、葛谷貞二、林 和彦、中野 功、石川哲也、後藤秀実

    JDDW2014  2014.10.24 

     More details

    Event date: 2014.10

    Language:Japanese   Presentation type:Poster presentation  

    Venue:東京   Country:Japan  

  105. C型慢性肝炎難治例におけるPegIFN・Ribavirin・Telaprevir3剤併用療法の治療効果

    本多 隆、石上雅敏、新家卓郎、今井則博、阿知波宏一、荒川恭宏、山田恵一、中野 聡、石津洋二、葛谷貞二、林 和彦、中野 功、石川哲也、片野義明、後藤秀実

    第50 回日本肝臓学会総会  2014.5.29 

     More details

    Event date: 2014.5

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  106. 分岐鎖アミノ酸によるNASHマウスモデルにおける肝脂肪抑制効果

    本多 隆、石上雅敏、新家卓郎、今井則博、阿知波宏一、荒川恭宏、山田恵一、中野 聡、石津洋二、葛谷貞二、林 和彦、石川哲也、中野 功、後藤秀実

    第100回日本消化器病学会総会  2014.4.23 

     More details

    Event date: 2014.4

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:東京   Country:Japan  

  107. 高齢者C型慢性肝炎に対するPegIFN・Ribavirin・Telaprevir3剤併用療法の治療効果

    本多 隆、片野義明、後藤秀実

    JDDW2013  2013.10.10 

     More details

    Event date: 2013.10

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Venue:東京   Country:Japan  

  108. The disappearance or decrease of tumor stain on contrast enhanced CT images after 2 weeks of sorafenib treatment predicts sorafenib efficacy in patients with advanced hepatocellular carcinoma International conference

    Kuzuya Teiji, Ishigami Masatoshi, Hayashi Kazuhiko, Honda Takashi, Goto Hidemi

    AASLD2013  2013.10 

     More details

    Event date: 2013.10

    Language:English   Presentation type:Poster presentation  

  109. Prevalence of resistance mutations against NS3 protease inhibitors in patients with hepatitis C virus genotype 1b and response to telaprevir plus pegylated-interferon-alpha 2b and ribavirin combination therapy International conference

    Hayashi Kazuhiko, Katano Yoshiaki, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Ishigami Masatoshi, Goto Hidemi

    AASLD2013  2013.10 

     More details

    Event date: 2013.10

    Language:English   Presentation type:Poster presentation  

  110. HBe抗体陽性B型慢性肝炎における経過予測に必要なウイルス遺伝子変異の検討

    本多 隆、片野義明、後藤秀実

    第49回日本肝臓学会総会  2013.6.7 

     More details

    Event date: 2013.6

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  111. Analysis of Late Onset (>= 3 Postoperative Months) Liver Dysfunction after Liver Transplantation. International conference

    Ishigami Masatoshi, Ishizu Yoji, Onishi Yasuharu, Kamei Hideya, Kuzuya Teiji, Honda Takashi, Hayashi Kazuhiko, Katano Yoshiaki, Ogura Yasuhiro, Goto Hidemi

    ILTS2013  2013.6 

     More details

    Event date: 2013.6

    Language:English   Presentation type:Poster presentation  

  112. Effect of combination therapy peginterferon alfa-2b and ribavirin on prevention of hepatocellular carcinoma in patients with chronic hepatitis C and normal aminotransferase levels International conference

    Takashi Honda, Yoshiaki Katano, Satoshi Nakano, Yoji Ishizu, Teiji Kuzuya T, Kazuhiko Hayashi, Masatoshi Ishigami, Hidemi Goto

    DDW2013  2013.5.18 

     More details

    Event date: 2013.5

    Language:English   Presentation type:Poster presentation  

    Country:United States  

  113. Real-Time Tissue Elastography for the Assessment of Liver Fibrosis in Patients With Chronic Hepatitis C and Correlation With Response to Pegylated-Interferon-Alpha 2B and Ribavirin Combination Therapy International conference

    Hayashi Kazuhiko, Katano Yoshiaki, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Ishigami Masatoshi, Goto Hidemi

    DDW2013  2013.5 

     More details

    Event date: 2013.5

    Language:English   Presentation type:Poster presentation  

  114. C型慢性肝炎難治例におけるペグインターフェロン・リバビリン併用療法の治療効果と発癌抑制効果

    本多 隆、片野義明、後藤秀実

    第99回日本消化器病学会総会  2013.3.21 

     More details

    Event date: 2013.3

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Venue:鹿児島   Country:Japan  

  115. Reactivation of HBV by anti-tumor necrosis factor-alpha therapy in a HBs antigen-negative patient with inflammatory bowel disease International conference

    Hayashi Kazuhiko, Katano Yoshiaki, Kuzuya Teiji, Honda Takashi, Ishigami Masatoshi, Itoh Akihiro, Omiya Naoki, Hirooka Yoshiki, Ando Takafumi, Goto Hidemi

    APASL2012  2012.12 

     More details

    Event date: 2012.12

    Language:English   Presentation type:Poster presentation  

  116. Effect of combination therapy peginterferon alfa-2b and ribavirin on prevention of hepatocellular carcinoma in advanced chronic hepatitis C International conference

    Honda T, Katano Y, Kuzuya T, Hayashi K, Ishigami M, Nakano I, Toyoda H, Kumada T, Yoshioka K, Goto H

    AASLD2012  2012.11.13 

     More details

    Event date: 2012.11

    Language:English   Presentation type:Poster presentation  

    Country:United States  

  117. 高齢者C型慢性肝炎におけるペグインターフェロン/リバビリン併用療法の治療効果と発癌抑制効果

    本多 隆、片野義明、後藤秀実

    第16回日本肝臓学会大会  2012.10.10 

     More details

    Event date: 2012.10

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Venue:神戸   Country:Japan  

  118. C型肝炎線維化進展例におけるペグインターフェロン/リバビリン併用療法の発癌抑制効果

    本多 隆、片野義明、中野 聡、増田寛子、及部祐加子、石津洋二、葛谷貞二、舘 佳彦、林 和彦、石上雅敏、中野 功、石川哲也、後藤秀実

    第48回日本肝臓学会総会  2012.6.8 

     More details

    Event date: 2012.6

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Venue:金沢   Country:Japan  

  119. A Case of HBeAg Serocoversion with Emerged Mutation of rt M 204 I/V in the Patients with Hepatitis B and HIV International conference

    Honda T, Katano Y, Kuzuya T, Tachi Y, Hayashi K, Ishigami M, Nakano I, Goto H

    APASL2012  2012.2.17 

     More details

    Event date: 2012.2

    Language:English   Presentation type:Poster presentation  

    Country:Taiwan, Province of China  

  120. HIV、HBV重複感染例でHBVに対するラミブジン耐性株の出現後HBe抗体陽性が持続し肝炎が沈静化した1例

    本多 隆, 片野義明, 中野 聡, 増田寛子, 及部祐加子, 石津洋二, 葛谷貞二, 舘 佳彦, 林 和彦, 石上雅敏, 中野 功, 石川哲也, 後藤秀実

    第39回日本肝臓学会西部会  2011.12.10 

     More details

    Event date: 2011.12

    Language:Japanese   Presentation type:Poster presentation  

    Venue:岡山   Country:Japan  

  121. Efficacy of Combination Therapy Peginterferon Alfa-2b and Rebavirin on Prevention of Hepatocellular Carcinoma in order Patients with Chronic Hepatitis C. International conference

    Honda T, Katano Y, Kuzuya T, Tachi Y, Hayashi K, Ishigami M, Nakano I, Goto H

    AASLD2011  2011.11.6 

     More details

    Event date: 2011.11

    Language:English   Presentation type:Poster presentation  

    Country:United States  

  122. CLINICAL SIGNIFICANCE OF SERUM HEPATITIS B CORE RELATED ANTIGEN (HBCRAG) IN CHRONIC HBV-INFECTED PATIENTS International conference

    Ishigami Masatoshi, Katano Yoshiaki, Hayashi Kazuhiko, Honda Takashi, Tachi Yoshihiko, Nakano Isao, Goto Hidemi

    ILTS2010  2011.10 

     More details

    Event date: 2011.10

    Language:English   Presentation type:Poster presentation  

  123. THE SUBSTITUTIONS IN AMINO ACID 70 IN THE HEPATITIS C VIRUS GENOTYPE 1B CORE REGION CORRELATE WITH LIVER STEATOSIS AND INSULIN RESISTANCE IN NON-OBESE PATIENTS WITH CHRONIC HEPATITIS C International conference

    Tachi Yoshihiko, Ishigami Masatoshi, Hayashi Kazuhiko, Honda Takashi, Katano Yoshiaki, Kuzuya Teiji, Goto Hidemi

    AASLD2011  2011.10 

     More details

    Event date: 2011.10

    Language:English   Presentation type:Poster presentation  

  124. ASSOCIATION BETWEEN A SINGLE-NUCLEOTIDE POLYMORPHISM OF INTERLEUKIN 28B AND MUTATIONS IN THE NS5A REGION OF HEPATITIS C VIRUS GENOTYPE 2 WITH RESPONSE TO PEGYLATED-INTERFERON-ALPHA 2B AND RIBAVIRIN COMBINATION THERAPY International conference

    Hayashi Kazuhiko, Katano Yoshiaki, Honda Takashi, Ishigami Masatoshi, Goto Hidemi, Toyoda Hidenori, Kumada Takashi

    AASLD2011  2011.10 

     More details

    Event date: 2011.10

    Language:English   Presentation type:Poster presentation  

  125. 高齢者C型慢性肝炎におけるペグインターフェロン/リバビリン併用療法の発癌抑制効果

    本多隆, 片野義明, 中野聡, 増田寛子, 及部祐加子, 小野幸矢, 石津洋二, 土居崎正雄, 葛谷貞二, 舘佳彦, 林和彦, 石上雅敏, 中野功, 石川哲也, 後藤秀実

    DDW-Japan2011(消化器病)  2011.9 

     More details

    Event date: 2011.9

    Language:Japanese   Presentation type:Poster presentation  

    Venue:福岡   Country:Japan  

  126. ペグインターフェロン、リバビリン併用療法における凝固因子の検討

    本多 隆、片野義明、増田寛子、及部祐加子、小野幸矢、石津洋二、清水潤一、土居崎正雄、舘 佳彦、林 和彦、石上雅敏、中野 功、石川哲也、後藤秀実

    第47回日本肝臓学会総会  2011.6.3 

     More details

    Event date: 2011.6

    Language:Japanese   Presentation type:Poster presentation  

    Venue:東京   Country:Japan  

  127. Additional Effect of Ribavirn During Peginterferon and Ribavirin Combination Therapy in Coagulation Factor International conference

    Honda T,Katano Y, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Goto H.

    DDW2011  2011.5.8 

     More details

    Event date: 2011.5

    Language:English   Presentation type:Poster presentation  

    Country:United States  

  128. 高齢者C型慢性肝炎に対するペグインターフェロン/リバビリン併用療法の効果

    本多 隆、片野義明、後藤秀実

    日本消化器病学会東海支部第113回例会  2010.11.27 

     More details

    Event date: 2010.11

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Venue:名古屋   Country:Japan  

  129. ASSOCIATION BETWEEN A SINGLE-NUCLEOTIDE POLYMORPHISM OF INTERLEUKIN 28B AND MUTATIONS IN THE CORE AND NS5A REGION OF HEPATITIS C VIRUS GENOTYPE 1B WITH RESPONSE TO PEGYLATED-INTERFERON-ALPHA 2B AND RIBAVIRIN COMBINATION THERAPY International conference

    Hayashi Kazuhiko, Katano Yoshiaki, Honda Takashi, Ishigami Masatoshi, Nakano Isao, Goto Hidemi

    AASLD2010  2010.10 

     More details

    Event date: 2010.10

    Language:English   Presentation type:Poster presentation  

  130. THE ROLE OF SUBSTITUTIONS IN THE CORE AND NS5A REGION OF HEPATITIS C VIRUS GENOTYPE 1B ON RESPONSIVENESS TO PEGYLATED INTERFERON AND RIBAVIRIN COMBINATION THERAPY International conference

    Katano Y., Ishigami M., Nakano I., Hayashi K., Honda T., Goto H.

    EASL2009  2009 

     More details

    Event date: 2009

    Language:English   Presentation type:Poster presentation  

  131. SHORT DURATION THERAPY OF PEGYLATED INTERFERON ALFA-2B PLUS RIBAVIRIN FOR HCV GENOTYPE 2 PATIENTS International conference

    Katano Yoshiaki, Ishigami Mosatashi, Nakano Isao, Hayashi Kazuhiko, Honda Takashi, Goto Hidemi

    AASLD2008  2008.10 

     More details

    Event date: 2008.10

    Language:English   Presentation type:Poster presentation  

  132. Dramatic decrease in bleeding events in hemophilia A patient with inhibitor during and after receiving anti-HCV treatment with ribavirin International conference

    Yamamoto K., Honda T., Toyoda H., Matsushita T., Goto H., Takamatsu J.

    ILTS2008  2008.7 

     More details

    Event date: 2008.7

    Language:English   Presentation type:Poster presentation  

  133. ASSESSMENT OF RELATIONSHIP BETWEEN SPLEEN VOLUME AND PLATELET COUNT AFTER LIVING DONOR LIVER TRANSPLANTATION IN JAPANESE ADULT PATIENTS International conference

    Ishizu Yoji, Ishigami Masatoshi, Nishino Masamichi, Honda Takashi, Hayashi Kazuhiko, Kamei Hideya, Nakamura Taro, Katano Yoshiaki, Kiuchi Tetsuya

    ILTS2008  2008.7 

     More details

    Event date: 2008.7

    Language:English   Presentation type:Poster presentation  

  134. Genotype2型C型慢性肝炎に対するPegIFNα-2b/Ribavirin併用療法(短期投与の検討)

    第44回日本肝臓学会総会  2008.6.6 

     More details

    Event date: 2008.6

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  135. 高齢者C型慢性肝炎におけるペグインターフェロン・リバビリン併用療法の効果

    第94回日本消化器病学会総会  2008.5.9 

     More details

    Event date: 2008.5

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  136. Efficacy of ribavirin plus pedinterferon-alfa in elderly patients with chronic hepatitis C International conference

    Honda T, Katano Y, Doizaki K, , Hayashi K, Ishigami M, Nakano I, Urano F, Yoshioka K, Toyoda H, Kumada T, Goto H

    EASL2008  2008.4.24 

     More details

    Event date: 2008.4

    Language:English   Presentation type:Poster presentation  

    Country:Italy  

  137. 凝固障害患者(主に血友病)におけるC型慢性肝炎に対するペグインターフェロンとリバビリン併用療法の効果

    第37回日本肝臓学会西部会  2007.12.8 

     More details

    Event date: 2007.12

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  138. C型慢性肝炎に対するペグインターフェロン・ リバビリン併用療法無効例の特徴

    2007.10.18 

     More details

    Event date: 2007.10

    Language:Japanese   Presentation type:Poster presentation  

    Country:Japan  

  139. Combination therapy with pegylated interferon ALFA-2B and ribavirin for patients with chronic hepatitis C and normal aminotransferase levels International conference

    Kotano Yoshiaki, Ishigami Mosatoshi, Nakano Isao, Hayashi Kozuhiko, Honda Takashi, Goto Hidemi

    AASLD2007  2007.10 

     More details

    Event date: 2007.10

    Language:English   Presentation type:Poster presentation  

  140. Genotype2型C型慢性肝炎に対するPegIFNα-2b/Ribavirin併用療法(少量投与の検討)

    本多 隆、片野 義明、中野 功、石上 雅敏、林 和彦、竹田 泰史、森井 正哉、西野 正路、後藤 新太郎、舘 佳彦、葛谷 貞二、岩田 浩史、土居崎 正雄、後藤 秀実

    第43回日本肝臓学会総会  2007.5.31 

     More details

    Event date: 2007.5

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  141. 高齢者C型肝炎に対するペグインターフェロン・リバビリン併用療法

    本多隆、片野義明、後藤秀実

    第93回日本消化器病学会総会  2007.4.19 

     More details

    Event date: 2007.4

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  142. Efficacy of ribavirin plus interferon-alfa in elderly patients with chronic hepatitis C International conference

    Honda T, Katano Y, Urano F, Hayashi K, Ishigami M, Nakano I, Yoshioka Y, Toyoda H, Kumada T, Goto H

    EASL2007  2007.4.13 

     More details

    Event date: 2007.4

    Language:English   Presentation type:Poster presentation  

    Country:Spain  

  143. Characteristic of the nonresponder to pegylated-interferon and ribavirin combination therapy in patients with hepatitis C virus genotype 1 infection International conference

    Honda T, Katano Y, Nakano I, Ishigami M, Hayashi K, Yoshioka K, Kumada T, Toyoda H, Goto H

    APASL2007  2007.3.29 

     More details

    Event date: 2007.3

    Language:English   Presentation type:Poster presentation  

    Country:Japan  

  144. ADDITIONAL EFFECT OF RIBAVIRIN DURING PEGINTERFERON AND RIBAVIRIN COMBINATION THERAPY International conference

    Honda T, Katano Y, Toyoda H, Kumada T, Hayashi K, Ishigami M, Nakano I, Yamamoto K, Takamatsu J and Goto H

    AASLD2007 Single Topic Conference  2007.3.2 

     More details

    Event date: 2007.3

    Language:English   Presentation type:Poster presentation  

    Country:United States  

  145. Efficacy of ribavirin plus interferon-alfa in elderly patients with chronic hepatitis C International conference

    Honda T., Katano Y., Urano F., Hayashi K., Ishigami M., Nakano I., Yoshioka K., Toyoda H., Kumada T., Goto H.

    EASL2007  2007 

     More details

    Event date: 2007

    Language:English   Presentation type:Poster presentation  

  146. C型慢性肝炎に対するペグインターフェロン・ リバビリン併用療法(無効例の検討)

    DDW-Japan2006(肝臓)  2006.10 

     More details

    Event date: 2006.10

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  147. ALT正常C型慢性肝炎に対するペグインターフェロン・リバビリン併用療法

    本多隆、片野義明、後藤秀実

    第41回日本肝臓学会総会  2006.5 

     More details

    Event date: 2006.5

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  148. Comparison of clinical and virological feature between genotype A and genotype C among patients with acute hepatitis B in Japan International conference

    Takeda Yasushi, Takano Yoshiaki, Hayashi Kazuhiko, Ishigami Masatoshi, Honda Takashi, Goto Hidemi

    APASL2006  2006.3 

     More details

    Event date: 2006.3

    Language:English   Presentation type:Poster presentation  

  149. ALT正常C型慢性肝炎に対するインターフェロン・リバビリン併用療法のウイルス学的効果

    第36回日本肝臓学会西部会  2005.11.25 

     More details

    Event date: 2005.11

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

    本多隆、片野義明、中野 功、石上雅敏、林 和彦、森井正哉、西野正路、竹田泰史、仲島さより、村山 睦、石黒裕規、葛谷貞二、岩田浩史、後藤秀実

  150. Anti-HCV agent, ribavirin, decreases events of bleeding in hemophilia patients, possibly by elevating the clotting activity of factor VII. International conference

    Yamamoto K, Honda T, Suzuki S, Toyoda H, Matsushita T, Kojima T, Goto H, Takamatsu J

    ASH2005  2005.11.16 

     More details

    Event date: 2005.11

    Language:English   Presentation type:Poster presentation  

  151. 高齢者C型慢性肝炎におけるインターフェロンとリバビリン併用療法の効果

    本多隆、片野義明、後藤秀実

    Digestive Disease Week-Japan 2005  2005.10 

     More details

    Event date: 2005.10

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  152. HBV genotype distribution differs in acute hepatitis from chronic hepatitis in Japan International conference

    Takeda Y, Katano Y, Hayashi K, Honda T, Goto H

    AMERICAN JOURNAL OF GASTROENTEROLOGY  2005.9 

     More details

    Event date: 2005.9

    Language:English   Presentation type:Poster presentation  

  153. C型慢性肝炎に対するインターフェロンリバビリン併用療法におけるNon-responderの検討

    本多隆、片野義明、石黒裕規、仲島さより、村山睦、竹田泰史、小田切英樹、西野正路、山田晋太郎、佐々木論実彦、横崎正一、石上雅敏、長野健一、中野功、矢野元義、後藤秀実

    第41回日本肝臓学会総会  2005.6 

     More details

    Event date: 2005.6

    Language:Japanese   Presentation type:Poster presentation  

    Country:Japan  

  154. JISscore,CLIPsore及びTokyo scoreを用いた肝細胞癌治療法別の予後

    第41回日本肝臓学会総会  2005.6 

     More details

    Event date: 2005.6

    Language:Japanese   Presentation type:Poster presentation  

    Country:Japan  

    本多隆、片野義明、矢野元義、中野功、長野健一、石上雅敏、横崎正一、佐々木論実彦、山田晋太郎、西野正路、小田切英樹、竹田泰史、仲島さより、村山睦、石黒裕規、後藤秀実

  155. JISscore及びCLIPscoreを用いた肝細胞癌治療法別の予後

    本多隆、片野義明、後藤秀実

    日本消化器病学会東海支部第101回例会  2005.1 

     More details

    Event date: 2005.1

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  156. C型慢性肝炎に対するインターフェロン・リバビリン併用療法後のインターフェロン単独療法追加による著効率の向上

    第8回日本肝臓学会大会  2004.10 

     More details

    Event date: 2004.10

    Language:Japanese   Presentation type:Poster presentation  

    Country:Japan  

    本多隆、片野義明、石黒裕規、仲島さより、村山睦、竹田泰史、小田切英樹、水谷哲也、佐々木論実彦、横崎正一、石上雅敏、長野健一、中野功、矢野元義、吉岡健太郎、後藤秀実

  157. C型慢性肝炎に対するインターフェロン・リバビリン併用療法におけるウイルス学、生化学的効果の検討

    2004.6 

     More details

    Event date: 2004.6

    Language:Japanese   Presentation type:Poster presentation  

    Country:Japan  

    本多隆、片野義明、石黒裕規、仲島さより、村山睦、竹田泰史、小田切英樹、水谷哲也、佐々木論実彦、横崎正一、石上雅敏、長野健一、中野功、矢野元義、吉岡健太郎、後藤秀実

  158. 高齢者C型慢性肝炎におけるインターフェロンとリバビリン併用療法の検討

    本多隆、片野義明、後藤秀実

    第90回日本消化器病学会総会  2004.4 

     More details

    Event date: 2004.4

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  159. 血友病患者におけるoccult HBV infectionの頻度とその臨床的意義

    第7回日本肝臓学会大会  2003.10.16 

     More details

    Event date: 2003.10

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

    本多隆、豊田秀徳、石黒裕規、仲島さより、竹田泰史、小田切英樹、林和彦、横崎正一、長野健一、片野義明、中野功、高松純樹、後藤秀実

  160. 急性肝不全および肝硬変での分岐鎖アミノ酸代謝の違い

    第39回日本肝臓学会総会  2003.5.22 

     More details

    Event date: 2003.5

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

    本多隆、下村吉治、福田吉秀、中野功、片野義明、横崎正一、林和彦、清水秀幸、清水富紀子、内藤岳人、小田切英樹、竹田泰史、仲島さより、村山睦、石黒裕規

  161. Differences in branched-chain amino acid catabolism between acute liver failure and liver cirrhosis in rats International conference

    Honda T., Shimomura. Y., Fukuda Y. Nakano I., Katano Y. Murakami T., Nagasaki M.

    Experimental Biology 2003  2003.4.13 

     More details

    Event date: 2003.4

    Language:English   Presentation type:Oral presentation (general)  

    Country:United States  

  162. Association of mutations in two PKR binding domains of hepatitis C virus genotype 3a and viral loads International conference

    Fukuda Y, Katano Y, Toyoda H, Yokozaki S, Hayashi K, Naito T, Shimizu H, Honda T, Otakiri H, Takeda Y, Nakashima S, Ishiguro H, Nakano I

    EASL2003  2003.4 

     More details

    Event date: 2003.4

    Language:English   Presentation type:Poster presentation  

  163. Responses to retraining of glucose uptake in rat skeletal muscle International conference

    Nagasiaki M, Shimomura Y, Bajotto G, Honda T, Oshida Y, Sato Y

    FASEB JOURNAL  2003.3.17 

     More details

    Event date: 2003.3

    Language:English   Presentation type:Poster presentation  

  164. Comparison between iron reduction therapy versus vitamin E treatment of chronic hepatitis C who previously failed interferon therapy International conference

    Hayashi K, Fukuda Y, Nakano I, Katano Y, Toyoda H, Yokozaki S, Naito T, Shimizu H, Shimizu Y, Honda T, Otakiri H

    APASL2002  2002 

     More details

    Event date: 2002

    Language:English   Presentation type:Poster presentation  

  165. Immunologic dynamics in a patient with tandem acute infection by HCV and HBV. International conference

    Fukuda Y, Nakano I, Katano Y, Nagano K, Yokozaki S, Hayashi K, Shimizu H, Shimizu F, Naito T, Honda T, Shizu Y, Hayakawa T

    EASL2001  2001.10 

     More details

    Event date: 2001.10

    Language:English   Presentation type:Poster presentation  

▼display all

Research Project for Joint Research, Competitive Funding, etc. 2

  1. HBV cccDNAの産生と維持に関わるウイルスおよび宿主因子の探索

    2022.4 - 2025.3

    日本医療研究開発機構(AMED)  肝炎等克服実用化研究事業 B型肝炎創薬実用化等研究事業 

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive

    Grant amount:\10000000

  2. B型肝炎ウイルス構造解析による薬剤応答性の評価と新規治療薬開発に関する研究

    2013.10 - 2016.3

    厚生労働省  科学技術振興調整費 

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive

KAKENHI (Grants-in-Aid for Scientific Research) 7

  1. HBs抗原陰性化に関わるB型肝炎ウイルス変異と腸内細菌叢が及ぼす免疫応答の解明

    Grant number:20K08382  2020.4 - 2023.3

    科学研究費助成事業  基盤研究(C)

    本多 隆

      More details

    Authorship:Principal investigator  Grant type:Competitive

    Grant amount:\4290000 ( Direct Cost: \3300000 、 Indirect Cost:\990000 )

  2. サルコペニア患者に対する腸内細菌叢への介入による効果的な運動療法の開発

    Grant number:21K11261  2021.4 - 2024.3

    科学研究費助成事業  基盤研究(C)

    石津 洋二, 本多 隆, 梅垣 宏行, 山本 健太

      More details

    Authorship:Coinvestigator(s) 

    サルコペニアに対する治療は運動療法であるが、十分な効果を得られないことが多い。近年、腸内細菌が産生する短鎖脂肪酸が骨格筋と関係している事が明らかになった。短鎖脂肪酸は腸内環境を整えることで炎症を抑え、それにより骨格筋の分解を抑える働きを持つ。さらに筋肉におけるエネルギー代謝にも関連し、運動時の易疲労性に対し予防的に働く。以上のことから、運動療法に短鎖脂肪酸産生を増加させるような腸内細菌叢への介入を加えることで、運動療法の効果を増強できるのではないかと考えた。そこで本研究は、サルコペニアに対し、腸内細菌叢への介入による効果的な運動療法を開発することを目的とする。

  3. 炎症性腸疾患における新規粘膜関連細菌叢検出法を用いた腸粘膜炎症プロファイルの作成

    Grant number:20K07801  2020.4 - 2023.3

    科学研究費助成事業  基盤研究(C)

    中村 正直

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive

  4. Studies on immunity and anti-inflammatory mechanisms regulated by diet and intestinal microenvironment

    Grant number:19H04042  2019.4 - 2022.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive

  5. Gut microbiota and therapeutic intervention in non-B,non-C hepatocellular carcinoma

    Grant number:17K09418  2017.4 - 2020.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    HONDA TAKASHI

      More details

    Authorship:Principal investigator  Grant type:Collaborative (industry/university)

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

  6. NASHにおけるアミノ酸代謝と肝脂肪改善及び進展抑制のメカニズム

    2014.4 - 2017.3

    科学研究費補助金  基盤研究(C)

    本多 隆

      More details

    Authorship:Principal investigator 

  7. 新規蛋白ナオフェンはエンドドキシンによる肝障害を抑制する新たな因子となりうるか

    2011.4 - 2014.3

    科学研究費補助金  基盤研究(C)

    馮 国剛

      More details

    Authorship:Coinvestigator(s) 

    LPS による肝障害において肝細胞アポトーシスの発生と新規物質naofen およびその結合物質であるannexinI との関連を調べ、エンドトキシン血症の治療に際して、新たなターゲットを検索する。

▼display all

Industrial property rights 1

  1. B型肝炎患者の臨床経過を予測する方法

    東海国立大学機構

     More details

    Date applied:2016.6

    Announcement no:2017-216939  Date announced:2017.12

    Country of applicant:Domestic   Country of acquisition:Domestic